leaders impacting the life-sciences industry
Transcription
leaders impacting the life-sciences industry
Celebration Inspired By LEADERS IMPACTING THE LIFE-SCIENCES INDUSTRY September 17, 2015 PHARMAVOICE 100 CELEBRATION 1 Celebrating Innovation and Inspiration in the Life Sciences Congratulations to this year’s PharmaVOICE 100 honorees, including our own Kara Dennis and Steve Smith! We commend PharmaVOICE for showcasing the outstanding work of industry thought leaders for over a decade. Thank you for fostering collaboration across the life sciences and for sharing innovative ideas and insights that are moving our industry forward. Steve Smith Chief Patient Advocate [email protected] | mdsol.com | +1 866 515 6044 Kara Dennis Managing Director of mHealth Celebration WELCOME LETTER T he idea behind PharmaVOICE — both magazine and online — created a forum for leaders to Read. Think. Participate. in the dynamic life-sciences industry. From molecule to market, PharmaVOICE has been providing the perspectives and insights of passionate and committed thought leaders for nearly 15 years. On the way to an industry trade show, about three years after the launch of PharmaVOICE, we were stuck in the Philadelphia airport. During what turned into a very, very long delay, we began talking about the people who we were scheduled to meet, how inspired we were by the work they were doing, and the difference they were making in the industry. Like the start of so many great innovations, one brainstorming idea led to another, and upon landing at our destination the following morning, we had also landed on the concept of the PharmaVOICE 100. So with an idea that started with a special publication that long ago August to celebrate the individuals behind the companies, products, brands, tools, and services that benefit patients worldwide, we have now recognized more than 1,000 of the industry’s most inspirational leaders from all sectors of the industry. We view ourselves as a convener — as evidenced by the tagline of our publication: The Forum for the Industry Executive — which is why this inaugural Celebration event is so special and exciting. We have the opportunity to bring together and recognize in person the men and women — the PharmaVOICE 100 and Red Jacket honorees — who are impacting change throughout the life-sciences industry and who inspire so many people every day. We have enjoyed getting to know each and every one of the honorees over the years, and we look forward to Taren Grom their inspired leadership for years to come. Editor, PharmaVOICE On behalf of everyone at PharmaVOICE, I want to thank all of our generous sponsors and attendees who made this event possible. We are proud to donate a portion of the proceeds from the event to Reach Out And Read, which prepares America’s youngest children to succeed in school by partnering with doctors to prescribe books and encourage families to read together. TABLE OF CONTENTS Letter from the Editor ............................................................................3 Agenda ....................................................................................................... 4 Executive Forum Panelists ...................................................................5 Table Curators ...........................................................................................6 Red Jacket Honorees — 2014 & 2015................................................8 PharmaVOICE 100 Celebration Sponsors ....................................10 Art of Inspiration .................................................................................... 16 Building Inspired Teams ..................................................................... 24 Inspiring Words.......................................................................................30 Inspiring Reads....................................................................................... 32 Inspiring Jobs.......................................................................................... 33 Inspired to Give....................................................................................... 34 PharmaVOICE 100 Honorees Through the Years...................... 36 PHARMAVOICE 100 CELEBRATION 3 Celebration AGENDA September 17, 2015 Apella Event Space • Riverpark, a Tom Colicchio Restaurant The Alexandria Center for Life Science TIME EVENT 6:00 pm Registration Opens 6:30 pm – 7:30 pm Executive Forum 7:30 pm – 10:30 pm Networking Event 8:00 pm – 8:30 pm Curated Table Discussions feel FEEL DEEPER. We have a lot of heart for what patients and customers go through when it comes to their healthcare. How do we know how they feel? We dig deep to find out. We engage with them honestly and through real connections we uncover how they feel inside. Their fears, concerns, and sometimes complete disconnection from their own health. Deep down in their hearts patients want to feel that healthcare companies and providers “get them.” Sometimes brand promotion and cool tactics aren’t enough. For clients looking to find new ways to engage customers, we also create unique content to help them connect with their customers on a more meaningful level. INFINITELY IN Are you interested in a heart-to-heart conversation with your customers? Call Matt Brown at 201-740-6160. www.guidemarkhealth.com Celebration EXECUTIVE FORUM PANELISTS JEFFREY S. ARONIN Chairman & CEO, Marathon Pharmaceuticals Mr. Aronin is a business leader, life-science investor, and philanthropist. He is also chairman and CEO of Paragon Pharmaceutical Capital. Before founding Marathon, he founded Ovation Pharmaceuticals Inc. and MATTER, a successful healthcare technology incubator to support entrepreneurs. Mr. Aronin was named a PharmaVOICE 100 honoree in 2005, 2008, and a Red Jacket honoree in 2015. DEBORAH DUNSIRE, M.D. President and CEO, FORUM Pharmaceuticals Dr. Dunsire has more than 25 years of scientific, clinical, operational, and commercial experience, as well as proven leadership in the biotech and pharma industries. Before joining FORUM in 2013, she served as President and CEO of Millennium Pharmaceuticals (now Takeda Oncology) from 2005 to 2013. Dr. Dunsire was named a PharmaVOICE 100 in 2010 and 2014 and a Red Jacket honoree in 2015. RICK KEEFER Global Chief Business Development Officer, Publicis Healthcare Communications Group Mr. Keefer is a 30-year industry veteran with broad-based experience in leading commercial operations. He was named Global Chief Business Development Officer of PHCG in January 2015. He was named a PharmaVOICE 100 in 2008, 2009, 2010, 2011, 2012, 2013, and a Red Jacket honoree in 2014. LEEROM SEGAL Co-Founder & CEO, Klick Health Mr. Segal is Co-founder and CEO of Klick Health, the world’s largest independent health agency. He is also co-author of the New York Times bestseller The Decoded Company: Know Your People Better Than You Know Your Customers. Mr. Segal was named a PharmaVOICE 100 honoree in 2012, 2013, 2014, and a Red Jacket honoree in 2015. CHRISTI SHAW US Country Head, President, Novartis Corp. & Novartis Pharmaceuticals Corp. Ms. Shaw has oversight responsibility for 27,000 associates over six divisions, for whom “More Moments for More Memories” isn’t just a mantra — it’s a mission. Through the lens of innovation, integrity, and inclusion, she leads the US General Medicines business and Novartis Corporation operations. Ms. Shaw was named a PharmaVOICE 100 honoree in 2015. PHARMAVOICE 100 CELEBRATION 5 Celebration TABLE CURATORS LAURIE COOKE, RPH CEO, Healthcare Businesswomen’s Association Ms. Cooke, a senior healthcare industry executive with an extensive career in both pharmaceutical and nonprofit arenas, assumed the role of CEO of the HBA nine years ago. She is well-versed in commercializing insights across the career continuum and drug development from preclinical to post approval. Ms. Cooke was named a PharmaVOICE 100 in 2009. DENISE DEMAN Founder, Chairman & CEO, Bench International With an indefatigable entrepreneurial spirit, Ms. DeMan has taken Bench International from its founding in 1974 to its eminence today as the premiere specialized retained executive search firm focused on life-sciences in the world. She is deeply committed to properly “shattering” the glass ceiling for women in the life-sciences. Ms. DeMan was named a PharmaVOICE 100 in 2009. CHRISTINE PIERRE CEO and Founder, RxTrials Inc. and Founder and President, Society for Clinical Research Sites (SCRS) Ms. Pierre is internationally known for her experience and expertise in clinical research site management and patient recruitment and retention for the clinical trials industry. Ms. Pierre was named a PharmaVOICE 100 in 2009 and 2013. STEPHEN SMITH Chief Patient Advocate, Medidata Solutions Mr. Smith was named chief patient advocate of Medidata Solutions in 2015. He is a staunch advocate for rare disease patients and plays a unique and critical role in the modernization of the clinical trials process, and serves on the Committee on Federal Legislation for the National MPS Society. Mr. Smith was named a PharmaVOICE 100 in 2015. CECI ZAK Chief Operating Officer, Healthcare, DAS-Omnicom Ceci Zak, who before joining DAS-Omnicom in 2013, spent more than 20 years with Sanofi and Roche, most recently in GM roles, where she drove innovative culture and commercial model change while exceeding targets and strategically positioning these companies for the future. Ms. Zak was named a PharmaVOICE 100 in 2006 and 2015. 6 PHARMAVOICE 100 CELEBRATION If the odds of lightening striking the same place twice are extraordinary, try three. Congratualtions to our own Michelle Keefe, Matt McNally and Bill Drummy for being honored among the PharmaVOICE 100 most inspiring people. It’s an honor to work beside you. Celebration RED JACKET HONOREES — 2014 & 2015 JEFFREY BERKOWITZ JEFFREY ARONIN Member, Board of Directors Infinity Pharmaceuticals 2014 Red Jacket Honoree Chairman, CEO, Founder Marathon Phramaceuticals 2015 Red Jacket Honoree Inspired By Inspired By NICK COLUCCI DEBORAH DUNSIRE, M.D. CEO Publicis Healthcare Communications Group 2014 Red Jacket Honoree President and CEO FORUM Pharmaceuticals 2015 Red Jacket Honoree MAKING A DIFFERENCE Inspired By SURVIVAL AMIR KALALI, M.D. VP and Head of the Neuroscience Center of Excellence Quintiles 2014 Red Jacket Honoree Inspired By SCIENCE Inspired By PATIENTS ALEX GORSKY Chairman and CEO Johnson & Johnson 2015 Red Jacket Honoree Inspired By PATIENTS RICK KEEFER FREDA LEWIS-HALL, M.D. Global Chief Business Development Officer Publicis Healthcare Communications Group 2014 Red Jacket Honoree Chief Medical Officer and Executive VP Pfizer 2015 Red Jacket Honoree Inspired By MAKING A DIFFERENCE Inspired By FAITH DAVID ORMESHER LEEROM SEGAL CEO, President, and Co-Founder closerlook, inc. 2014 Red Jacket Honoree Co-Founder and CEO Klick Health 2015 Red Jacket Honoree Inspired By PASSION DONATO TRAMUTO CEO and Chairman Physicians Interactive 2014 Red Jacket Honoree Inspired By 8 MAKING A CHANGE IN THE WORLD SAVING LIVES PHARMAVOICE 100 CELEBRATION Inspired By PATIENTS Celebration PHARMAVOICE 100 CELEBRATION SPONSORS DIAMOND SPONSOR Bench International is a retained, performance milestone accountable Life Science executive search firm, established in 1974. We are One Global Team, No Borders, No Boundaries, One Global Budget, allowing us to focus exclusively on our clients’ needs. Our 40 year scorecard: • 98% retained searches successfully completed • 75% of candidates remain with same company five years or longer with an average of two promotions in five years • Within 2-5 weeks of search launch vetted candidates are delivered • 90% of our clients are long-term client partners. Visit: benchinternational.com solution taking shape, he connected with businessman Tarek Sherif to start a company that would focus solely on advancing clinical testing. Today, Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. Medidata is committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations. Visit: mdsol.com Diego. Alexandria has a longstanding and proven track record of providing its client tenants with collaborative environments that enhance productivity and foster innovation. Additional information, please visit: are.com inVentiv Health is a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) help clients improve their performance to deliver much-needed therapies to market. With 14,000 employees providing services to clients in 70 countries, PLATINUM SPONSOR The Medidata journey started in 1999 when a lab scientist, founder Glen de Vries, looked for a way to make clinical trials run better. With a SaaS technology GOLD SPONSORS Alexandria Real Estate Equities, Inc. (NYSE:ARE) is the largest and leading office REIT uniquely focused on collaborative science and technology campuses in urban innovation clusters, including Greater Boston, San Francisco, New York City, San 10 PHARMAVOICE 100 CELEBRATION At inVentiv Health, we combine the best strategic brains in the biopharmaceutical industry with passion, drive and endless energy to help bring your product from lab to life. Please join us in congratulating three exemplary individuals on their inclusion in the PharmaVOICE 100 Most Inspiring People. Kim Johnson, President PALIO Mike Menta, Chief Operating Officer Campbell Alliance Jeanine O’Kane, Managing Director Biosector 2 inVentivHealth.com Celebration PHARMAVOICE 100 CELEBRATION SPONSORS GOLD SPONSORS inVentiv Health designs best practices, processes and systems to enable clients to successfully navigate an increasingly complex environment. Visit: inventivhealth.com The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving some of the most important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. We bring innovative products, services and solutions to people throughout the world. Our research and development strategy focuses on identifying medical needs, and harnessing the best science in the world, whether from our own laboratories, or through strategic relationships and collaborations. Visit: janssen.com advertising and promotion. Visit: ochww.com Ogilvy CommonHealth Worldwide— the health behavior change specialists of Ogilvy & Mather—committed to creativity and effectiveness in healthcare communications, everywhere. OCHWW provides marketing services including behavioral insights, content strategy and management, digital, interactive and new media services, marketing analytics and research, media planning, medical education, payer marketing and market access, professional advertising and promotion, public relations, relationship marketing, social media and social listening, and wellness and consumer Publicis Healthcare Communications Group (PHCG) is the largest healthoriented agency network in the world. A division of Publicis Groupe, PHCG manages top-tier agencies specializing in promoting innovative solutions in advertising, digital, branding, message delivery, market access, and medical communications. PHCG’s brands are Saatchi & Saatchi Health, Digitas Health LifeBrands, Publicis Life Brands, Razorfish Health, Heartbeat Ideas, Discovery, insync Customer Insights, Publicis Health Media, Publicis Touchpoint Solutions, beacon healthcare, Maxcess, and Verilogue. Visit: publicishealthcare.com that does everything on a deeper level. It starts with digging deeper to uncover hidden truths that lead them to a more honest engagement with patients and customers. Then, from branding and advertising to social media and e-learning, they design and tailor tactics to help people learn about their clients’ messages in their own unique way. It’s not an approach you see every day. With Guidemark Health, be ready for a deeper engagement with your customers, your patients and your agency. Visit: guidemarkhealth.com SILVER SPONSORS Guidemark Health is a new breed of agency. Guidemark Health is an agency 12 PHARMAVOICE 100 CELEBRATION T he power of our thinking compels you. Ready to cast out the conventional? Contact Shaun Urban at 973.352.1000 Celebration PHARMAVOICE 100 CELEBRATION SPONSORS SILVER SPONSORS Reltio Cloud delivers reliable data, relevant insights and recommended actions so companies can be right faster. Companies rely on Reltio data-driven applications and modern data management for better planning, customer engagement and risk management. Visit: reltio.com Target Health Inc. is a New York City based full service e*CRO dedicated to all aspects of Regulatory Affairs, Clinical Research, Biostatistics, Data Management, Internet-Based Clinical Trials, Software Development, Strategic Planning and Drug and Device Development. Target Health is committed, through creative collaboration, to serve the pharmaceutical community with knowledge, experience, technology and connectivity. Our pledge is to optimize the life cycle of drugs, biologics and devices with expertise, leadership, innovation and teamwork. Visit: targethealth.com UBC leads the market in providing integrated, comprehensive clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with leading-edge technologies, allowing for the best patient and healthcare provider experience. Comprehensive, end-to-end services cover product and patient population characterization during development and market entry, as well as a focus on the patient experience, safety, and adherence. Visit: ubc.com BRONZE SPONSORS AmerisourceBergen is a global healthcare solutions leader that drives innovative partnerships with health systems, manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare continuum. AmerisourceBergen shapes healthcare delivery through a range of services and solutions including clinical trial 14 support, commercialization, global sourcing and distribution, business and practice management consulting and patient support services. Learn more about these end-to-end solutions at AmerisourceBergen.com. Sunovion Pharmaceuticals Inc. is dedicated to discovering, developing and PHARMAVOICE 100 CELEBRATION commercializing scientifically advanced therapeutic products that are focused on helping patients suffering from central nervous system and respiratory disorders, as well as other illness. The company name, which is representative of the life-affirming energy of the sun and the power of innovation, reflects Sunovion’s portfolio of currently marketed pharmaceutical products and pipeline candidates; and serves to emphasize the company’s ongoing commitment to improve the lives of patients everywhere. Visit: sunovion.com Celebration THE ART OF INSPIRATION MATT GIEGERICH Chairman & CEO Ogilvy CommonHealth Worldwide 2005 “Ultimately our business is about people. I am responsible not only for the global success of Ogilvy CommonHealth Worldwide but also people’s personal success.” - Matt Giegerich “The knowledge that what I do, the decisions that I make, and how I innovate can translate into new therapeutics that will help people with serious illnesses is truly motivating.” - William Strohl WILLIAM STROHL VP and Head, Janssen BioTherapeutics Janssen R&D, Johnson & Johnson 2015 “I continue to dedicate my career to improving the clinical research process and meeting the increasing demands of the industry.” - Lisa La Luna LISA LA LUNA Senior VP, Business Development, ePharmaSolutions, a WIRB-Copernicus Group Company 2007 MERYL ZAUSNER Executive VP, Novartis 2014 RAKESH DIXIT VP, R&D, Toxicology MedImmune 2015 16 “We empower our employees to push the boundaries of what’s possible to advance science and the development of life-changing medicines.” - Rakesh Dixit PHARMAVOICE 100 CELEBRATION Celebration “As consumers become more sophisticated, driven somewhat by their engagement with digital and social media, the industry has to innovate in kind.” - Asaf Evenhaim ASAF EVENHAIM CEO, Crossix 2012 “I am inspired by people who are willing to roll up their sleeves, open their hearts, and make the world a more compassionate environment.” - Lelia O’Connor LELIA O’CONNER RYAN SAADI, M.D. Global Market Access & Policy Leader, Oncology, Janssen Research & Development LLC 2011, 2015 “I try to always pull the discussion around to the core question: how do we get patients the access they need to innovative therapies?” - Ryan Saadi President Ngal So Authentic Leadership Group 2008 ELAINE RIDDELL “I tell people no matter who you are, where you work, or what you do, you have an impact on saving people’s lives and that inspires me every day.” - Meryl Zausner CEO DECISIO LLC 2008 “The leaders of tomorrow will be those who learn to collaborate with their stakeholders, not just ‘sell’ to them.” - Elaine Riddell PHARMAVOICE 100 CELEBRATION 17 Celebration THE ART OF INSPIRATION OSNAT BENSHOSHAN “To innovate or encourage others to do so, one must inspire an intense desire to simply do it better, preceded by a deep understanding of how things are currently done.” - Osnat Benshoshan Chief Marketing Officer, SERMO 2015 “With leadership comes accountability and responsibility to all those who view you as a leader.” - Dr. Theodore Search “It’s about empowering and enabling genius while having fun along the way.” - Melinda Richter MARC SIROCKMAN Executive VP, General Manager, Artcraft Health 2015 DR. THEODORE SEARCH CEO, Skipta 2015 MARYELLEN ROYLE “The best we can do as team leaders is provide and maintain a supportive work culture that allows talent to grow and thrive.” - Maryellen Royle 18 President, North America, Tonic Life Communications 2015 PHARMAVOICE 100 CELEBRATION “Our goal is to help patients make informed decisions so that they can help themselves with making the right choice for their disease state and where they are in their healthcare continuum.”- Marc Sirockman Celebration MELINDA RICHTER Head, Johnson & Johnson Innovation JLABS 2015 “I believe that to be successful in any endeavor, passion keeps you focused and persistent.” - Neill Walsdorf “I love to take something and make it better, it’s my passion in life and something I get the most personal satisfaction from.” - Nicole Woodland-DeVan NEILL “GOBIE” WALSDORF President, Mission Pharmacal Company 2015 NICOLE WOODLAND-DEVAN Senior VP, Buying Services & Deliverables, Compas Inc. 2015 “As a leader you need to be supportive and create an environment where people are willing to try something new.” - Melissa Easy LISS EASY Founder of DrugDev and President, DrugDev SiteStart 2015 REMO COLARUSSO VP, Manufacturing and Technical Operations, Janssen Supply Chain, Janssen Pharmaceuticals 2015 “I set an expectation that we all innovate in each of our jobs; every job is two-fold — do the job and figure out a way to do it better.” - Remo Colarusso PHARMAVOICE 100 CELEBRATION 19 Celebration THE ART OF INSPIRATION MATT BROWN CEO Guidemark Health 2014 MIKE MENTA Chief Operating Officer Campbell Alliance, an inVentiv Health company 2015 “There is nothing that inspires me more than to have the ability to work with a talented group of people and be challenged daily in an industry I love.” - Mike Menta ILYSSA LEVINS President and Founder, Center for Communication Compliance 2012 “The biggest highlight to me has been seeing people I have mentored go on to do great things and achieve their goals.” - Matt Brown “I am committed and passionate about the causes I feel strongly about, including advancing therapies for people born with rare diseases and by having more diversity in the workforce.”- Wendy White WENDY WHITE VP, Rare Disease Dohmen Life Science Services 2012, 2015 20 “I am inspired by connecting individuals and organizations that have the capacity to multiply each other’s impact.” - Eve Dryer PHARMAVOICE 100 CELEBRATION “I actively mentor because it’s critical to have someone who you can trust and ask the question, ‘how did I do?’ and know they will answer you honestly.” - Ilyssa Levins EVE DRYER President Eve Dryer Healthcare Consulting 2007, 2015 ENTERPRISE STRATEGY IT’S IN OUR GENOME IT’S WHAT WE WERE BORN TO DO Redefining what marketing means to pharma. Creating engagements with value and purpose. Leading integrated services with our digital DNA. SEO MULTICHANNEL When you’re born to do something, it comes naturally. Realize your potential with integrated services from Intouch Solutions. INTOUCHSOL.COM/GENOME MEDIA MOBILE SOCIAL CRM DATA & ANALYTICS CONSULTING HCP + CONSUMER CREATIVE Celebration THE ART OF INSPIRATION STEPHEN SMITH Chief Patient Advocate, Medidata 2015 “I believe in a cross-stakeholder approach to modernizing drug development to increase the number of cures for serious and life-threatening disorders.” - Stephen Smith “I am moved by the talent, passion, and conviction of women who are committed to furthering the HBA’s mission today and fueling our aspirations for the future.” - Laurie Cooke LAURIE COOKE CEO, Healthcare Businesswomen’s Association 2009 CECI ZAK “I believe the more you share, the more you give; the more you do, the wealthier you will always be.” - Denise DeMan Chief Operating Officer for Healthcare, DAS-Omnicom 2006, 2015 “Mentoring is very important to me, because there is no greater gratification in anything I do than to help others dream dreams and realize them.” - Ceci Zak DENISE DEMAN Founder, Chairman, CEO Bench International 2015 “Be aware of everything you do that has your name attached to it.”- Christine Pierre 22 PHARMAVOICE 100 CELEBRATION CHRISTINE PIERRE CEO and Founder, RxTrials Inc. and Founder and President, Society for Clinical Research Sites (SCRS) 2009, 2013 am honored Congratulations to the PharmaVOICE 100 Class of 2015 We’re proud to see our leaders recognized for another year running Our therapeutic depth creates strong connections with both sponsors and sites So that patients worldwide can get the medicines they need, sooner Congratulations to Alan Ong and Michael Gibertini for being named in this year’s PharmaVOICE 100. We are proud of all our talented staff whose therapeutic expertise gives us our unique focus and depth. To learn more about how our work helps connect you to stronger clinical development programs, visit incresearch.com Celebration BUILDING INSPIRED TEAMS E xecutives who boldly transform their company’s talent operations to be as innovative as their business strategy see dramatic, measurable improvements in their company’s performance and ability to accelerate growth, according to a recent report from PwC. Inspired Results fiercer than ever, the time for talent innovation is now. By viewing their people as assets on Innovating a talent strategy their balance sheet, and by aligning to fuel business priorities business goals with the talent strategy can drive measurable needed to achieve them, companies can performance gains at every see 75% higher revenue growth, 77% stage of execution, including: better strategy implementation, and • 70% improved process 85% stronger financial performance turnaround times overall, according to PwC’s Project • 30+% lower turnover Management Institute, Talent • 20% improved Management - State of the Market productivity report. They also attract and retain • 15-25% HR operations employees not just as bright new hires savings but as future leaders. Deborah Dunsire, M.D., CEO, • 30% uptick in innovation Talent innovation rethinks and FORUM Pharmaceuticals ideas. transforms previously siloed processes 2010, 2014, and 2015 Red Jacket As part of PwC’s annual into a unified talent ecosystem, how the digital world is changing the CEO survey, results show a definitive integrating designs to create a whole workplace. But business leaders are shift in the level of concern among greater than the sum of each part, also looking for adaptable people — business leaders worldwide over the ultimately built to advance a company’s talent with a wide range of skills and impact of skills shortages on their business strategy, accelerate business the willingness to keep learning and business, in spite of a market increase performance, and cultivate a modern apply what they know wherever and in business confidence. Three-quarters workforce that’s diverse, engaged, and whenever they’re needed. of all CEOs ranked it as the biggest delivering on its goals. PwC analysts say what is clear is that threat to growth — a 10% jump from With today’s ever-shifting market organizations can’t rely on recruiting last year and a 46% increase from six forces and the battle for talent proving people as they’ve always done in the years ago. past — they need to look in new The survey also found “As a leader if you don’t develop places, geographies, and from new or that people with strong the next level of leadership, you alternative pools of talent. In other technology skills are are putting your company’s future words, companies have to think outside particularly sought at risk.” — Dr. Deborah Dunsire the box. after — an indication of [ ] 24 PHARMAVOICE 100 CELEBRATION Celebration know they can be. Mr. Gallo outlines seven qualities that he says all inspiring leaders share: ignite enthusiasm, navigate a course of action, sell the benefit, paint a picture, invite participation, reinforce optimisim, and encourage potential. In a recent Harvard Jeff Aronin, Founder, Chairman, CEO Business Review article, Marathon Pharmaceuticals Jack Zenger and Joseph 2005, 2008, and 2015 Red Jacket Folkman discussed what top executives want from their leaders (see side bar). They report that according to an IBM survey of Carmine Gallo, a columnist for Forbes, 1,700 CEOs in 64 countries, the three wrote recently that one-third of U.S leadership traits that most mattered employees are so unhappy they are were the ability to focus intensely thinking of leaving their jobs. He poses on customer needs, the ability to collaborate with “I offer the freedom for people colleagues, and the ability to be creative and make mistakes to inspire. and I set a bold vision to align These experts also the team.” — Jeff Aronin turned their attention to the question of whether leaders could the question: how is it possible that learn to become more inspiring. To unhappy, unmotivated, and disengaged find out they did another study of employees could possibly offer 882 executives from data collected exceptional customer service or develop over the last three years, who were exciting, innovative products that measured on 16 different competencies move your brand forward? Mr. Gallo and encouraged to focus efforts on responds they can’t, that’s why it’s up to improving one of them. Focusing on company leaders to satisfy what he says the 310 who chose to improve their is a person’s “chief want;” someone who ability to inspire others they found that will inspire employees to be what they “Chief Want” [ ] INSPIRED LEADERS Of the 16 leadership competencies Harvard Business Review most frequently measures, they report that inspiration is the one trait that stands out. Their data reveal that the ability to inspire creates the highest levels of employee engagement and commitment. It is what most powerfully separates the most effective leaders from the average and leasteffective leaders. How do they do it? They set stretch goals with their team. They spend time developing their subordinates. They engage in highly collaborative behavior. They encourage those around them to be more innovative. They establish a clear vision. They make emotional connections. PHARMAVOICE 100 CELEBRATION 25 Celebration BUILDING INSPIRED TEAMS [] “What really resonates is purpose tied to a deep sense of mission.” — Christi Shaw Inspired Leadership In the continually evolving lifesciences environment, leaders need to keep an open mind, listen carefully to their marketplaces, Christi Shaw, US Country Head, and understand the needs of President, Novartis Corp. & Novartis Pharmaceuticals Corp. the patients their companies 2015 ultimately serve. Therefore, it is as a group they made impressive more important than ever for leaders strides — moving from the 42nd to inspire their team members to percentile (that is, below average) achieve their professional goals, thereby to the 70th percentile. This is a ensuring sustainable success for their statistically significant positive organizations. gain, and compelling evidence that “Talent development is a critical when leaders use the right approach component within my own company,” they can learn to become more says Deborah Dunsire, M.D., CEO, inspiring. FORUM Pharmaceuticals. “I believe In other words, Mr. Zenger and Mr. that as a leader if you don’t develop the Folkman say with awareness, good next generation of leadership, you are putting your company’s future at risk. feedback, and a plan of development, It’s an absolutely critical business leaders are able to improve this priority to ensure that you have a most important of all leadership pipeline of leaders in development all competencies. the time.” When it comes “Mentoring and focusing on people to her personal development are really the most inspirational important things that I do.” leadership style, Dr. — Alex Gorsky Dunsire says as a [] 26 PHARMAVOICE 100 CELEBRATION leader you don’t have to be perfect, but each day, you need to be better than you were the day before and if you keep doing that, you can build greatness into people and organizations. For Jeffrey Aronin, founder, CEO, and chairman of Marathon Pharmaceuticals, inspired leadership is about setting a vision. “My leadership style is to hire very talented people, put them in roles where they are able to have creativity and freedom, and clearly define the mission so everybody is aligned,” he says. “I like to think I offer a clear vision as to where the company is going. People know their role, but they also recognize what everybody else Alex Gorsky, Chairman and CEO Johnson & Johnson 2010, 2014, and 2015 Red Jacket Bring together and uncover relationships across a vast amount of data to understand markets, drive revenue and reduce risk through actionable, real-time predictive insights. Cloud-based Reltio data-driven applications enable the management of key accounts, affiliations, HCP/HCOs, products, plan and payers, patients, key opinion leaders, clinical trials and more. Learn more at Reltio.com iconic With 30 years of experience, Tonic is the go-to healthcare PR agency for both established companies and ambitious start-ups. contact us Maryellen Royle, President +1 215 928 2368 | [email protected] | toniclc.com Celebration BUILDING INSPIRED TEAMS [] motivate your associates so far with financial incentives,” she says. Ms. Shaw nurtures an empowering culture of “leading at all levels.” She is known for her willingness to continually challenge the status quo. She’s also a firm advocate for inclusiveness in the workplace. Ms. Shaw empowers her associates to speak up and encourages employee engagement, as she understands that an engaged workforce is critical to helping patients and ensuring business success. Rick Keefer, global chief business development officer, Publicis Healthcare Communications Group, says he is probably like many leaders, “I obsess about making sure that we bring the right people into the right environment.” — Leerom Segal brilliant people. My belief is that if a company can get the culture right, it’s not just attractive to the right individual, but it also creates an environment where those people thrive, and when people are happy, they make your clients happy, and when your clients Leerom Segal, Co-Founder and CEO, are happy, they reward you with Klick Health loyalty and growth. This is a very 2012, 2013, 2014 and 2015 Red Jacket virtuous cycle that shapes our is doing and we all hold each other belief system. And of course, it’s easier accountable.” said than done to operationalize this Leerom Segal, co-founder and CEO type of model and takes a lot of work.” of Klick Health and author of the bestAlong those same lines, selling book The Decoded Company, Christi Shaw, U.S. Country believes that teams do amazing things Head, president of Novartis when they are inspired by challenges Corp. and president of Novartis that they believe in and when the right Pharmaceuticals Corp., says what team is in place. really resonates with people is “The most important thing we do purpose tied to a deep sense of as an organization is obsess about our mission. culture,” he says. “For the past 18 years, “It’s easy to get caught up we’ve been on a quest to figure out how chasing the bottom line, but to best build a center of gravity for I’ve found that you can only [] “The team has always been the most important piece of what I do. I surround myself with really good, really passionate people.” — Jeff Berkowitz 28 PHARMAVOICE 100 CELEBRATION Jeff Berkowitz, Member, Board of Directors, Infinity Pharmaceuticals 2009, 2010, 2012 and 2014 Red Jacket Celebration high standards, and I think it’s just the opposite,” he says. “By creating an environment where people feel that they can be themselves, where they can speak up and speak out, and at the same time know that they’re going to be challenged in an inspiring way, they are willing to give their best, which ultimately allows me to make the best decisions.” There are clearly discussions and decisions that leaders make every day, particularly in the space of healthcare, that require an incredible amount of rigor, focus, and serious “Whatever role you play or whatever area deliberation, you operate in, the ultimate goal is to he says. facilitate better healthcare for patients.” “I think — Rick Keefer when the balance is right — an inclusive environment communications or facilitate better where people don’t feel that they dialogues or increase the educational need to walk on eggshells, where they stream — helps facilitate better can openly speak their minds, where healthcare; I think this helps give diverse opinions are welcome — I’m people passion and a common goal.” absolutely convinced that this ensures Over the years, Alex Gorsky, that all issues are brought into the chairman and CEO of Johnson & discussion, are considered, and that Johnson, has found that developing again, ultimately, the right decisions get personal relationships while creating made,” Mr. Gorsky says. an informal environment — one still Admittedly, he says this approach held to high standards — engages and requires a lot of active engagement, and inspires people to do things that they this is one of the natural dynamics of wouldn’t think that they’re capable of being a leader that can sometimes be doing on their own. intimidating. “Sometimes, there’s the belief that a Jeff Berkowitz, currently a board leader can’t be informal and still have in that he doesn’t view himself as an inspirational leader, contrary to popular opinon. “I’m happy that people are able to derive some inspiration from my approach, which is that whatever role you play or whatever area you operate in, the ultimate goal is to facilitate better healthcare for patients,” he says. “I think I’ve always done a good job of reminding people why we’re in this industry and that what we do — whether it’s developing a tool that allows patients to access better [] Rick Keefer, Global Chief Business Development, Publicis Healthcare Communications Group 2008, 2009, 2010, 2011, 2012, 2013 and 2014 Red Jacket member at Infinity Pharmaceuticals, is focused on the team and team dynamics. “For me the team has always been the most important piece of what I do,” he says. “I like to surround myself with really good, really passionate people. I also have to believe in what I’m doing, I have to be passionate about it, and this translates to those around me. “From a people perspective, I have been able to identify passionate and smart people who I know can go well beyond what it is that they’re doing on a day-to-day basis,” Mr. Berkowitz continues. “This is very motivating to teams; they know that as long as they’re doing good work and as long as they’re challenging the status quo, there are going to be opportunities for them within the groups that I lead.” PHARMAVOICE 100 CELEBRATION 29 Celebration InspiringWORDS FUN FACT The Golden Rule Inspiration can come in many forms and from a variety of sources. Our PharmaVOICE 100 have provided us with some of their favorite axioms that have guided them in their leadership journeys. “Do not impose on others what you do not wish for yourself” JEANNE ZUCKER , 2008 “The advancement of women worldwide through programs designed to sponsor them, and help them prepare for and assume leadership roles is now more critical than ever.” RON COHEN, 2009 “Live your life so that, at the end, your last thought looking back is: that was all right.” “Your greatest learnings in life come from personal experience.” “Don’t wait for anybody to tell you what you need to do; define yourself and create your own unique value.” SHAUN URBAN, 2009 “Work hard, and good things will happen.” LANCE CONVERSE , 2005 “How a leader handles challenges is key; it’s about consistency in the approach, regardless how big or small the issue: resolve the problem,figure out why it became a problem in the first place, and ensure the problem doesn’t recur.” NICK COLUCCI 2006, 2010, 2013 and 2014 Red Jacket “Curiosity contributes mightily to being effective.” 30 ANN MOHAMADI, 2013 MICHAEL PARISI, 2012 ROBERT REBAK, 2011 “Do what really interests you, not what you are supposed to do.” CONFUCIUS 479BC PHARMAVOICE 100 CELEBRATION PETER KIRK, 2012 “Everything can always be better.” DRUG & DEVICE DEVELOPMENT IS OUR BUSINESS • FullServiceeCRO • ExtensiveFDAInteractions • BroadRangeofExperience • Over35RegulatoryApprovalsWorldwide CHAMPION OF THE PAPERLESS CLINICAL TRIAL CONTACT: Jules T. Mitchel, MBA, Ph.D. President,TargetHealthInc. 261MadisonAvenue24thFloor 212-681-2100ext.0 [email protected] www.targethealth.com Celebration InspiringREADS From books that outline lessons in leadership to those that define new business models, the PharmaVOICE 100 identify what’s hot on their reading lists. Dr. Sandra Lottes, 2015 Lean In: Women, Work, and the Will to Lead by Sheryl Sandberg FUN FACT Printed Book vs. e-Book First book mass printed 1454 First e-reader patent 1949 Michael Fergusson, 2012 Kim Johnson, 2015 Predictably Irrational: The Hidden Forces That Shape Our Decisions by Dan Ariely What Got You Here Won’t Get You There by Marshall Goldsmith Scott Plevy, M.D., 2015 Tom Hospodar, 2015 Faruk Capan, 2009, 2012 Scott Ballenger, 2007 Humble Inquiry: The Gentle Art of Asking Instead of Telling by Edgar H Schei Collective Genius: The Art and Practice of Leading Innovation by Linda Hill The Advantage: Why Organizational Health Trumps Everything Else In Business by Patrick Lencioni Seeing What’s Next: Using Theories of Innovation to Predict Industry Change by Clayton Christensen Bill Drummy, 2008, 2015 The Information: A History, A Theory, A Flood by James Gleick 32 Ric Cavieres, 2015 No Ordinary Disruption: The Four Global Forces Breaking All the Trends by Richard Dobbs and James Manyika PHARMAVOICE 100 CELEBRATION Lisa Giles, 2015 Michelle Marlborough, 2014 Rocket Fuel: The One Essential Combination That Will Get You More of What You Want from Your Business by Gino Wickman and Mark C. Winters The Phoenix Project: A Novel about IT, DevOps, and Helping Your Business Win by Gene Kim, Kevin Behr and George Spafford Celebration “I would be a physician. I spend so much time thinking about therapies, I’ve gotten to understand the power of the medical profession.” Inspring Kara Dennis, 2015 JOBS The PharmaVOICE 100 have chosen careers in the life-sciences industry and they are passionate about making a difference. Over the years, we’ve asked our honorees if they could chose a second profession, what might that be. Darlene Dobry, 2011 “I’ve always had a passion for writing;–I have so many ideas in my head for books or songs.” Marc Weiner, 2013 “College professor - in my idealistic world, education would be as fulfilling as working in the healthcare space.” Max Kanevsky, 2015 “Most college professors don’t teach in a way that inspires students to change the world. I would like to try it differently.” Laura Liotta, 2015 “I would be a psychologist. I find people, and what makes them tick, fascinating.” Jeanine O’Kane, 2015 “I would be a baker, and create a memorable experience for people.” FUN FACT Job YOU MIGHT NOT HAVE KNOWN EXISTED PHARMA ARTISAN One possible outcome of the push for personalized medicine. PHARMAVOICE 100 CELEBRATION 33 Celebration InspiredTO GIVE The PharmaVOICE 100 not only positively impact their companies and their teams, they are philanthropists who give generously of their time, resources, and talents to organizations dedicated to helping those in need. FUN FACT MOST Giving Country UNITED STATES and MYANMAR are tied for the most giving country Tina Fascetti, 2014 Liver Life Walk Organ transplant. Tina lost her brother after two liver transplants due to infection, but that doesn’t take away the fact it is the most amazing gift a person and family can give. Additionally, her best friend received a liver transplant and is thriving because of the generosity of an amazing family who Julie Kempf, 2009, 2013 Good Grief, which helps children and teens cope with loss. Julie lost her mother to cancer when she was 15, and working with Good Grief has given her an opportunity to create a legacy for her mom. lost their child on Christmas Eve. She has also gotten close to the transplant teams of two teaching hospitals and have found them to be truly amazing people in so many ways. The decisions they are forced to make on a daily basis due to the lack of available organs and their ability to perform such a complex surgery are nothing short of heroic. Terry Herring, 2007, 2008 Big Brothers, Big Sisters (BBBS); the Kirkwood Camp; and a yearly Youth Mission Trip. Vera Rulon, 2015 Stanley Woodland, 2008 Have A Chance Walk, a program that provides support for brain tumor research. Founding member of Arts Angels Inc., which supports the arts in a public school district. Bill Drummy, 2008, 2015 Lynn O’Connor Vos, 2005 The Jed Foundation is the nation’s leading organization that works to promote emotional health and prevent suicide among college and university students. The Hole in the Wall Gang Camp and The National Multiple Sclerosis Society Charlotte Sibley, 2006 American Kidney Fund Board of Trustees 34 PHARMAVOICE 100 CELEBRATION Sunovion salutes PharmaVOICE for a decade of honoring the industry and recognizing leadership A proud sponsor of the PharmaVOICE 100 Celebration, Sunovion is a leading pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the psychiatry, neurology and respiratory disease areas to improve the lives of patients and their families. Sunovion Pharmaceuticals Inc. Visit us at www.sunovion.com and connect with us on Twitter @Sunovion and LinkedIn. Shaping healthcare delivery takes past experience and forward thinking. It takes a global healthcare solutions leader. ItTakesAmerisourceBergen.com 33684-15-264463_ABC_Hindsight_3.75x5_PV_4C_r1.indd 1 8/31/15 1:55 PM Sunovion_Ad_PharmaVOICE100.indd 1 DIAMOND SPONSOR PLATINUM SPONSOR GOLD SPONSORS SILVER SPONSORS SILVER SPONSORS Thank You! 8/31/15 11:19 A Celebration PHARMAVOICE 100 HONOREES THROUGH THE YEARS P harmaVOICE is proud to have recognized more than 1,000 of the most inspiring, motivating, innovative leaders throughout the life-sciences industry for more than decade. Their dedication to their companies, teams, and communities has had a positive ripple effect on tens of thousands of individuals as well as the hundreds of thousands of patients who they ultimately serve. Please note, honorees are listed with their company at the time of recognition; for multiple-time honorees, it is the company of the most recent honor. A Adrian Adams, Auxillium Pharmaceuticals, 2012 Colleen Adams, Wyeth, 2009 Julian Adams, Ph.D., Infinity Pharmaceuticals Inc., 2008, 2011 Thomas Adams, Association of Clinical Research Professionals, 2005 Jeffrey Adelglass, M.D., Research Across America, 2014 Lisa Adler, Takeda Pharmaceuticals, 2014 Ann Aerts, M.D., Novartis AG, 2014 Michael Agard, Sanofi-Aventis, 2010 Gadi Aharoni, Ph.D., Algorithmic Research Inc., 2006 Christopher Ahlberg, Ph.D., Spotfire, 2005 Mark J. Ahn, Ph.D., Hana Biosciences, 2005 Murray L. Aitken, IMS Health, 2005 Johanna Allston, Ph.D., bioCapture, 2010 Al Altomari, Barrier Therapeutics Inc., 2007 Rich Altus, PDR Network, 2012 Carol Ammon, Endo Pharmaceuticals, 2006 Gaynor Anders, MMG, 2012 Diana Anderson, Ph.D., D.L. Anderson International Inc, 2006 Karla Stricker Anderson, PwC, 2009 Randy Anderson, Ph.D., PPD, 2010 Vicente Anido Jr., Ph.D., ISTA Pharmaceuticals, 2010 Kevin Aniskovich, Intelecare Compliance Solutions Inc., 2008 Vaughn Anthony, D. Anderson & Company, 2009 Elizabeth Izard Apelles, Greater Than One Inc., 2009 Jason Appel, Sanofi-Aventis, 2008 Valdo Arnera, M.D., PHT Corp, 2008 Barry Arnold, M.B., B.Ch., AstraZeneca, 2005 Jeffrey S. Aronin, Ovation Pharmaceuticals Inc., 2005, 2008, and 2015 Red Jacket Howard Asher, Life Sciences Information Technology Global Institute, 2005 36 Mara Aspinall, On-Q-ity, 2010 Ami Assayag, Specialty Diets, 2006 Ahsan Awan, PharmaLink, 2006, 2007, 2009, 2011 B Lee Babiss, Ph.D., Roche, 2009, 2012 Joan F. Bachenheimer, BBK Worldwide, 2005 William Bailey, Pharm.D., Daiichi Sankyo Inc., 2007 John Bailye, Dendrite International, 2005 David Baker, Alcobra, Ltd., 2015 Dan Baker, Janssen Research & Development, 2013 Matthew Baker, Compass IRB, 2011, 2012 Robert Baldini, Esprit Pharma, 2007 Frank Baldino Jr., Ph.D., Cephalon, 2007, 2011 Scott Ballenger, Trial Acceleration Institute Inc, 2007 John Philip Bamforth, Ph.D., Eli Lilly and Company, 2007 Mohan Bangalore, Ph.D., Pfizer, 2010 Mark Bard, Manhattan Research, 2006 Natalie Barndt, Cephalon, 2006 Jackie Barnes, Pfizer, 2006 Alain D. Baron, M.D., Ethos Pharmaceuticals Inc., 2008 Jack Barrette, Yahoo Inc, 2005, 2006 Richie Bavasso, Exploria SPS, 2007 Donna Beardsworth, Beardsworth Group, 2011 Michael Beckloff, Beckloff Associates, 2009 Gary Beer, Independent Investment Professional, 2009 Nancy Beesley, HCB Health, 2012 Ken Begasse Jr., Concentric Healthcare, 2008 Christopher Begley, Hospira Inc., 2007 Dominic Behan, Ph.D., Arena Pharmaceuticals, 2013 Christian Behrenbruch, Ph.D., ImaginAb, 2013 John Benbrook, MMG, 2006 Osnat Benshoshan, SERMO, 2015 Jeff Berg, Ph.D., AbelsonTaylor, 2014 Donna Berk, M.S., Target Research Associates Inc., 2005 PHARMAVOICE 100 CELEBRATION Jeffrey Berkowitz, Walgreens, 2009, 2010, 2012, and 2014 Red Jacket Charlotte Berlin, Astellas Pharma US, 2009 Stan Bernard, M.D., Bernard Associates LLC, 2006 Michelle Berrey, MD, MPH, Chimerix, 2015 David Berry, Pronutria, 2013 Jay Bigelow, MicroMass Communications, 2008 Glenn Bilawsky, i3, 2005, 2010 Howard Birndorf, Nanogen, 2007 Ross Bjella, DDN Pharmaceutical Logistics, 2009 Stella Blackburn, Quintiles, 2015 Wendy Blackburn, Intouch Solutions, 2010 Jody Blakeway, athenahealth, 2013 Larry Blankstein, Ph.D., Genzyme, 2009 Paul Bleicher, M.D., Ph.D., PhaseForward, 2005 Andrew Blight, Ph.D., Acorda Therapeutics Inc., 2011 Timothy Block, Ph.D., Pennsylvania Biotechnology Center, 2011 Jeff Boatman, QPharma, 2010 Dan Bobear, Palio, 2010 Kim Boericke, Quintiles, 2012 Joseph Bolen, Ph.D., Millennium: The Takeda Oncology Company, 2011 Jay Bolling, Roska Healthcare, 2010 Mark Booth, Takeda Pharmaceuticals North America, 2006 Alexis Borisy, Warp Drive Bio, 2012 Susan Bornstein, eClinical Solutions, 2010 Jerome Boscia, M.D., Janssen Research & Development, 2012 Debbie Botwick, Pfizer, 2009 Calep A. (Joe) Boyd III, MCS Healthcare Public Relations, 2011 Joan Bradley, Pharm.D., The JB Ashtin Group, 2009 Damian Braga, Sanofi Pasteur, 2013 Gregg Brandyberry, GlaxoSmithKline, 2008 Richard Branton, Merck, 2010 David Brennan, AstraZeneca, 2010 Philip Brennan, marketRx, 2005 Bonnie Brescia, BBK Worldwide, 2005 Bob Brooks, GlaxoSmithKline, 2006 Michael Brooks, PPD, 2014 Matt Brown, ICC Lowe, 2014 Jessica Brueggeman, MicroMass Communications, 2013 David Bruggeman, Clinical Research Advantage, 2013 Kurt Brykman, Parexel Consulting, 2006 Dyan Bryson, Inspired Health Strategies, 2012 Thomas Buckley, StayinFront Inc., 2006 Brendan Buckley, M.D., D.Phil., Firecrest Clinical, 2010 Graham Bunn, Ph.D., Medidata Solutions Worldwide, 2010 Andrew Burns, WorldOne, 2013 Jonathan Bush, athenahealth, 2013 Jon Butko, MediciGlobal, 2008 Arif Butt, SelectScience, 2014 Calvin Butts, CMI Communications Media Inc, 2013 Marc Buyse, IDDI, 2013 William Buzzeo, Cegedim Compliance Solutions, 2011 Bill Byrom, Ph.D., ClinPhone, 2008 C Jerry Cacciotti, Strategic Decisions Group, 2006 John Campbell, Campbell Alliance Group Inc., 2006 Rich Campbell, Regan Campbell Ward McCann, 2007 Tom Campbell, Healthy Advice Networks, 2010 Faruk Capan, Intouch Solutions Inc., 2009, 2012 Judy Capano, Wishbone/ITP Inc., 2009 Walter Capone, MMRF, 2013 Molly Carnes, M.D., University of Wisconsin-Madison, 2014 Randall Carpenter, M.D., Seaside Therapeutics, 2011 Daniel Carr, M.D., Innovative Drug Delivery Systems, 2005 J. Martin Carroll, Boehringer Ingelheim Pharmaceuticals Inc, 2012 Jay Carter, AbelsonTaylor, 2005, 2006 Kathleen Case, Columbia MedCom Group Inc., 2006 Michael Castagna, Pharm.D., BristolMyers Squibb, 2011 Celebration Kathleen Castore, Sanofi, 2012 Ric Cavieres, EY Advisory Life Science, 2015 Marco Chacón, Ph.D., Paragon Bioservices, 2012 Jaswinder Chadha, marketRx, a Cognizant company, 2009 Jane Chin, Ph.D., Medical Science Liaison Institute LLC, 2006 Bob Chandler, Chandler Chicco Companies, 2014 T. G. Chandrashekhar, Ph.D., Ranbaxy Research Laboratories, 2007 Dave Chapman, Ogilvy CommonHealth, 2007 Scott Chappel, OvaScience, 2013 Olivier Chateau, GlaxoSmithKline, 2009 Will Cheung, Comprehend Systems, 2014 Simon Chin, Iris BioTechnologies Inc., 2008 William Ciambrone, Shire Human Genetic Therapies, 2010 William Clapper, MTI Information Technologies LLC, 2006 Chad Clark, UBC, 2010 Cathryn Clary, M.D., Ipsen Biopharmaceuticals, 2012 William Claypool, M.D., Phoenix Data Systems Inc., 2006 Mary Clegg, SynteractHCR, 2013 Terri Clevenger, Continuum Health Communications, 2012 John Cline, etrials Worldwide Inc., 2005 Martine Clozel, M.D., Actelion Pharmaceuticals Ltd., 2008 Jamie Cobb, MicroMass Communications, 2010 Matthew Coffey, Ph.D., Oncolytics Biotech Inc., 2007 Isaac Cohen, OMD, Bionovo, 2006 Jaime Cohen, TCN e-Systems LLC, 2008 Ron Cohen, M.D., Acorda Therapeutics Inc., 2009 Remo Colarusso, Janssen Pharmaceutical Companies of Johnson & Johnson, 2015 N. Anthony Coles, M.D., Onyx Pharmaceuticals, 2011 Francis Collins, M.D., Ph.D., NIH, 2013 Steve Collis, AmerisourceBergen, 2013 Nicholas Colucci, Publicis Healthcare Communications, 2006, 2010, 2013 and 2014 Red Jacket Peg Connelly, Kforce Clinical Research Inc., 2009 Reid Connolly, evoke Interaction, 2011, 2014 Alyson Connor, MicroMass Communications, 2011 Lance Converse, ePharmaLearning, 2005 Laurie Cooke, R.Ph., Healthcare Businesswomen’s Association, 2009 Lynnette Cooke, Kantar Health, 2010 Grant Corbett, Behavior Change Solutions, 2005 Nancy Corkum, Johnson & Johnson Corp., 2009 Mark Corrigan, M.D., Sepracor, 2009 Brian Corvino, PharmaStrat Inc., 2008 Rob Cosinuke, Epocrates, an athenahealth service, 2015 Lisa Costantino, EMD Serono, 2012 Santino Costanzo, Organogenesis Inc., 2007, 2008 Anthony Costello, Nextrials Inc, 2006 Scott Cotherman, Corbett Accel Healthcare, 2005 Carrie Cox, Schering-Plough Corp., 2007 Teri Cox, Cox Communications, 2005 Rose Crane, Epocrates, 2010 Stanley T. Crooke, MD, PhD, Isis Pharmaceuticals, 2015 William Crown, Ph.D., i3, 2006 Donna Cryer, CryerHealth, 2011 Sean Cunliffe, Neuromed Pharmaceuticals, 2008 David Cunningham, TrialCard, 2014 Mark Cunningham, Janssen Research & Development, 2014 Mark Curran, Ph.D., Janssen Research & Development, 2013 Tyrone Curran, Harrison & Star, 2011 Jim Curtis, Remedy Health Media, 2013, 2014, 2015 Stephen Cutler, Ph.D., Kendle, 2011 D Matthew D’Ambrosio, Sunovion Pharmaceuticals, 2014 Bassil Dahiyat, Ph.D., Xencor Inc., 2007 Joseph Daley, GSW, 2011 Susan Dallabrida, Ph.D., PHT, 2014 Patricia Daly, Metropolitan Research Associates, 2005 Rich Daly, TAP Pharmaceuticals Products Inc., 2006 Zubin Damania, M.D., Downtown Project Las Vegas, 2013 Tim Davis, Exco InTouch, 2013 Yolanda Davis, Spaulding Clinical, 2011 Kate Dawson, M.D., Biogen Idec, 2014 Neil de Crescenzo, Oracle Health Sciences, 2013 David de Graaf, Ph.D., Selventa, 2012 Stephan de la Motte, M.D., SynteractHCR, 2014 Jose De Leon, Daiichi Sankyo Inc., 2008 Jonathan de Pass, M.B. Ch.B., Evaluate Ltd., 2014 Glen de Vries, Medidata Solutions Worldwide, 2006 Jay Deakins, Deacom Inc., 2009 Gregg Dearhammer, i3 Statprobe, 2008, 2011 Jean-Francois Dehecq, SanofiAventis, 2007 Martine Dehlinger-Kremer, SynteractHCR, Inc., 2015 Craig DeLarge, Novo Nordisk Inc., 2007 Denise DeMan-Williams, Bench International, 2009 Evan Demestihas, M.D., R.Ph., Science Oriented Solutions, 2006 Kara Dennis, Medidata Solutions, 2015 Barbara Deptula, Shire Pharmaceuticals, 2007 Peter Derycz, Derycz Scientific, 2010 Camille DeSantis, Guard Dog Brand Development LLC, 2008 Phil Deschamps, GSW, 2006 Susan Desmond-Hellmann, M.D., Genentech, 2006 Lucy Deus, SupplyScape Corp., 2009 Jack Devlin, AstraZeneca, 2007 Cheryl Dewey, Blue Chip Healthcare Marketing, 2012 Punit Dhillon, OncoSec Medical Inc, 2013 Dan Diaz, SPRI Clinical Trials-Global, 2015 Peter DiBiaso, Pfizer Global Research and Development, 2007 Sheng Ding, Ph.D., Fate Therapeutics, 2010 Gerianne Tringali DiPiano, FemmePharma Global Healthcare Inc., 2008 Michelle Dipp, M.D., Ph.D., GlaxoSmithKline, 2009 Rakesh Dixit, MedImmune, 2015 Darlene Dobry, Ogilvy CommonHealth, 2011 Brad Doerschuk, PharmaMed Research, 2012 Daniel Donovan, Envision Pharma Inc, 2007, 2008 Susan Dorfman, Skila, 2008, 2009 Chris Downey, Genentech, 2005 Larry Downey, Teva Neuroscience, 2007 Joe Doyle, HCB Health, 2014 Tracy Doyle, Phoenix Group Holdings, 2006 Kathleen Drennan, Iris Global Clinical Trial Solutions, 2008 Nancy Dreyer, MPH, Ph.D., Outcome, 2007, 2014 Jeffrey Drezner, M.D., Ph.D., Clinical Care Options, 2007 Marty Driscoll, Reliant Pharmaceuticals Inc., 2005 Glen Drummond, Gilead Sciences, 2009 Bill Drummy, Heartbeat Ideas & Heartbeat West, 2015 Bill Drummy, Heartbeat Digital, 2008 Eve Dryer, Eve Dryer Healthcare Consulting, 2007, 2015 Michael du Toit, Digitas Health LifeBrands, 2014 Filipe Duarte, Merck & Co. Inc., 2008 Denise Duca, Acorda Therapeutics Inc., 2013 Joanne Duckman, Torre Lazur McCann, 2010 David Dunn, ApotheCom, 2010 Deborah Dunsire, M.D., Millennium: The Takeda Oncology Co., 2010, 2014, and 2015 Red Jacket Cameron Durrant, M.D., MBA, Anavex Life Sciences, 2005, 2006, 2007, 2010 E Melissa Easy, DrugDev, 2015 Lisa Ebert, Medicus Life Brands, 2010 Steven V. Edelman, M.D., Taking Control of Your Diabetes, 2008 Elliot Ehrich, M.D., Alkermes, 2012 Marianne Eisenmann, Chandler Chicco Companies, 2012 Barry Eisenstein, M.D., Cubist Pharmaceuticals Inc., 2007 Anders Ekblom, M.D., Ph.D.,D.D.S., AstraZeneca, 2005 Richard Elliott, Medical Marketing Service Inc, 2006 Amy Ellis, MedAvante, 2013 Russell Ellison, M.D., FibroGen Inc, 2006 Doug Engfer, invivodata, 2005 David Epstein, Novartis, 2010 Dave Escalante, Cegedim, 2013 Dixie Esseltine, Takeda Oncology, 2015 Richie Etwaru, IMS Health, 2015 David Evans, Octagon Research Solutions, 2006 Mary Hensley Evans, imc2 Health, 2009 Asaf Evenhaim, Crossix Solutions, 2012 F John Farinacci, ResearchPoint, 2009 Tina Fascetti, PulseCX, 2014 Ali Fattaey, Ph.D., ACT Biotech Inc., 2011 Michael Feehan, Ph.D., Observant LLC, 2007 Bruce Feinberg, DO, Cardinal Health, 2015 PHARMAVOICE 100 CELEBRATION 37 Celebration PHARMAVOICE 100 HONOREES THROUGH THE YEARS Lisa Fell, MediciGroup, 2007 Michael Fergusson, Ayogo Games, 2012 Prabhavathi Fernandes, Cempra Pharmaceuticals, 2011 Karen Ferrante, M.D., Millennium: The Takeda Oncology Company, 2012 Marc Ferrara, Jobson Medical Information, 2008 Thomas Finn, The Procter & Gamble Co., 2008 Fereydoun Firouz, Serono, 2006, 2008 Jennie Fischette, Concentric Health Experience, 2014 Mark Fishman, M.D., Novartis, 2013 Tara Fitzgerald, INC Research, 2014 Sander Flaum, Flaum Idea Group, 2011 Aaron Fleishman, BBK Worldwide, 2014 Christina Fleming, Ph.D., Delta Pharma, 2010 Candice Fliedner, Avid Bioservices Inc., 2009 Frederick Foard, Communications Media Inc., 2009 Marie Foegh, M.D., Agile Therapeutics, 2012 Colleen Foley, Abbott, 2008 Robert Forrester, Verastem, 2014 Sonja Foster, Clinical Connexion, 2007 Tracy Foster, Lash Group, 2014 Edward Fotsch, M.D., PDR Network, 2011 Geoffrey Francis, Novozymes, 2009 Leo Francis, Ph.D., Publicis Medical Education, 2010, 2012 Tim Frank, Triple Threat Communications, 2014 Scott Freedman, Monitorforhire.com, 2005 Joy Frestedt, Frestedt Inc., 2011 Robert Friedman, M.D., InfoMedics, 2006 Patricia Furlong, Parent Project Muscular Dystrophy, 2012 Barry Furr, Ph.D., AstraZeneca, 2006 G Leslie Gaber, Leslie Gaber Associates, 2010 Erin Gainer, Ph.D., HRA Pharma, 2010 Christopher Gallen, M.D., Ph.D., Neuromed Pharmaceuticals, 2007 Kirk Gallion, Octagon Research Solutions Inc., 2007 Richard Gams, M.D., Novella Clinical, 2014 Jean-Jacques Garaud, M.D., Roche, 2008 Timmy Garde, Star Group Communications, 2012 38 Jud Gardner, Comprehend Systems, 2013 Philip Garland, BearingPoint Inc, 2008 Paula Garrett, Eli Lilly and Company, 2009 Peter Gassner, Veeva Systems, 2010 Joe Gattuso, MBS/Vox and CommonHealth, 2006 Henry Gazay, Medimix International, 2011 Stephen Gerard, TGaS Advisors, 2008 Philip P. Gerbino, Pharm.D., University of the Sciences in Philadelphia, 2005 Heather Gervais, Epocrates, an athenahealth service, 2014 Daniel P. Getman, Ph.D., Pfizer, 2006 Kenneth Getz, Tufts Center for the Study of Drug Development and CISCRP, 2007 Melynda Geurts, D. Anderson & Company, 2008 Daniel Ghinn, Creation Healthcare, 2014 Dr. Michael Gibertini, INC Research, 2015 Matt Giegerich, Ogilvy CommonHealth, 2005 Lisa Giles, Giles & Associates Consultancy / Optivara, 2015 Nancy Gillett, DVM, Ph.D., Charles River Laboratories, 2006 Dennis Gillings, CBE, Ph.D., Quintiles, 2005 Steven Gilman, Ph.D., Cubist Pharmaceuticals, 2009 Steven Girgenti, Ogilvy Healthworld, 2008 Kathy Giusti, The Multiple Myeloma Research Foundation, 2009, 2014 John Glasspool, Novartis, 2014 George Glatcz, Vox Medica, 2009 Neil Gleghorn, Kallik Ltd, 2014 Richard Gliklich, M.D., Outcome, 2010 Kevin Glover, B. Braun Medical Inc., 2007 Marcia Goddard, Torre Lazur McCann, 2009 William “Al” Godley, Edge Dynamics, 2007 Mark Goldberg, M.D., Perceptive Informatics Inc, 2006 Linda Goldman, Inclinix, 2011 Peter Goldschmidt, Sandoz Inc, 2015 Dan Goldsmith, Veeva, 2014 Jennifer Goldsmith, Veeva Vault, 2011 Boris Golubtsov, M.D., Ph.D., Chiltern International, 2005 Alex Gorsky, Johnson & Johnson, 2010, 2014, and 2015 Red Jacket Ginger Graham, Amylin Pharmaceuticals Inc., 2006 PHARMAVOICE 100 CELEBRATION Susan Grant, Planning For Hope, 2013 Fabio Gratton, Ignite Health, 2009, 2014 Kelly Gratz, inVentiv Commercial Solutions, 2012 Peter Gray, ICON, 2006 Mary Anne Greenberg, Alliance Healthcare Information, 2011 Daniel Greenleaf, VioQuest Pharmaceuticals, 2006 Janet Greeson, Ph.D., Samaritan Pharmaceuticals, Inc, 2008 Sylvie Grégoire, Pharm.D., Shire Human Genetic Therapies, 2011 Alberto Grignolo, Ph.D., Parexel International, 2008 Kristin Gross, Acurian, 2013 John Guarino, Palio + Ignite, 2013 Adele Gulfo, AstraZeneca, 2007 Thomas Gunning, EMD Serono, 2009 Gene Guselli, InfoMedics Inc., 2007 H Tuan Ha-Ngoc, AVEO Pharmaceuticals Inc., 2009 David Hahn, The Medical Affairs Company, 2013 Victoria Hale, Ph.D., Institute for OneWorld Health, 2005 Nick Halkitis, MediciGlobal, 2010 Laurie Halloran, Halloran Consulting Group, 2010 Steve Hamburg, Wishbone, 2010 Yusuf Hamied, Ph.D., Cipla Ltd., 2010 Mark Hanley, Clinical Research Advantage, 2012 Karen Hanson, Ph.D., BioStrategy Partners, 2009 Beth Harper, Centerphase Solutions Inc., 2011 John Harrington, Sanofi-Aventis, 2008 Paul Harrington Jr., Palio + Ignite, 2014 Sarah Harrison, AstraZeneca, 2007 Michael Harte, etrials Worldwide Inc., 2008 John Hartigan, MediciGroup Inc., 2006 Shannon Hartley, Rosetta, 2012, 2014 Dan Hassan, Regan Campbell Ward Group, 2010 Fred Hassan, Schering-Plough Corp., 2009 Michael Hayden, Teva Pharmaceuticals, 2015 Fran Heller, Exelixis, 2011 Maggie Helmig, Ogilvy Healthworld, part of Ogilvy CommonHealth Worldwide, 2015 Jean Hendrickson, Catalyst Clinical Resourcing, 2014 Michael J. Hennessy, Intellisphere, 2006 Joseph Herring, Covance, 2005 Terrell Herring, inVentiv Health, 2007, 2008 Jamie Heywood, PatientsLikeMe, 2013 Raymond Hill, IMS Health, 2007 Maurice Hilleman, Ph.D., Merck, 2005 Kerry Hilton, HCB Health, 2013 Lyndi Hirsch, Genentech, 2009 Jeffrey Hoffman, Euro RSCG Life Catapult, 2011 Bob Hogan, Triple Threat Communications, 2015 Eduard Holdener, M.D., Roche, 2005 Louisa Holland, Sudler & Hennessey, 2005 Regina Holliday, The Walking Gallery of Healthcare, 2014 Jane Hollingsworth, NuPathe Inc, 2008 Elizabeth Holmes, Theranos, 2015 Robert Holmes, Ph.D., Qforma, 2012 Tom Hospodar, Sunovion Pharmaceuticals Inc., 2015 Leigh Householder, GSW, 2012 Keith Howells, Medidata Solutions Worldwide, 2008 James Hoyes, EMD Serono, 2010 Patrick Hughes, CluePoints, 2015 Thomas Hughes, Ph.D., Zafgen Inc., 2009 Dr. Franz Humer, Roche, 2006 William Humphries, Stiefel, a GSK company, 2011 Nicole Hyland, Natrel, 2015 I Edward Ikeguchi, M.D., Medidata Solutions Worldwide, 2005 Diane Iler-Smith, Ogilvy Healthworld, 2014 Mike Innaurato, Purdue Pharma LP, 2012 J Jonathan Isaacs, Evoke Health, 2014 Yuichi Iwaki, M.D., Ph.D., MediciNova, 2012 Paul Janssen, M.D., Ph.D., Janssen Pharmaceutica, 2005 Lisa Jenkins, Ph.D., Virtual Regulatory Solutions, 2015 Joe Jimenez, Novartis, 2010, 2011 Michael Jirousek, Ph.D., Catabasis Pharmaceuticals, 2011 Greg Johnson, Strategic Business Research, 2009 Kim Johnson, PALIO, 2015 Jeff Jonas, Shire, 2013 Ken Jones, Compas Inc. and CMI Inc., 2007 Roger Jones, Ph.D., Qforma, 2011 Celebration Deborah Jorn-Muthard, ScheringPlough Pharmaceuticals, 2006 K John Kaiser, Acadia Pharmaceuticals Inc, 2009 Amir Kalali, M.D., Quintiles, 2005, 2006, 2008, 2011, 2012, and 2014 Red Jacket Clifford Kalb, Wood Mackenzie Inc., 2005 Allison Kalloo, Clinical Ambassador, 2012 Joanne Kamens, Addgene, 2013 Julie Kampf, JBK Associates, 2009, 2013 Max Kanevsky, Pinnacle 21, 2015 Harris Kaplan, Healogix, 2011 Anjali Kataria, Conformia Software, 2005 Karen Katen, Pfizer, 2006 Jay Katz, Rockpointe Corp, 2008 Mitchell Katz, Ph.D., Purdue Pharma LP, 2011 Michelle Keefe, Publicis Touchpoint Solutions, 2014, 2015 Rick Keefer, Publicis Selling Solutions, 2008, 2009, 2010, 2011, 2012, 2013, and 2014 Red Jacket Greg Keenan, MD, Astra Zeneca, 2015 Bruce Kehr, M.D., InforMedix, 2007 Dennis Keith, Ph.D., Cubist Pharmaceuticals Inc, 2008 Ken Keller, Amgen, 2007 Ian Kelly, Red Nucleus, 2012 Mike Kelly, Kantar Health, 2013 Candace Kendle, Pharm.D., Kendle, 2010 Kyle Kennedy, The Medical Affairs Company, 2009 Nick Kenny, Ph.D., INC Research Inc., 2008 Debbie Kenworthy, Ortho-McNeil Janssen Pharmaceuticals, 2008 Iya Khalil, Ph.D., GNS Healthcare, 2014 Mehmood Khan, M.D., Takeda Global Research and Development Center Inc., 2007 Matt Kibby, BBK Worldwide, 2006 Marc Kikuchi, AmerisourceBergen, 2015 Jinsoo Kim, Image Solutions, 2005 Joseph Kim, Ph.D., Inovio Pharmaceuticals, 2013 Deborah Jones King, Empatha Inc, 2006 Jennifer King, The Medical Affairs Company, 2010 Rachel King, GlycoMimetics, 2013 Jeffrey Kingsley, D.O., SERRG Inc., 2009 Peter Kirk, WorldOne, 2012 Linda Kitlinski, Endo Pharmaceuticals, 2008 Bob Klein, Blue Chip Healthcare Marketing, 2013 Tami Klerr-Naivar, PRA, 2012 James Knipper, J. Knipper & Co. Inc., 2009 Geert Kolvenbag M.D., Ph.D., F.F.P.M, AstraZeneca, 2008 Roger Korman, Ph.D., DMD/Aptilon, 2012 Rob Kotin, Ph.D., Voyager Therapeutics, 2014 Jeff Kozloff, Verilogue, 2010 Daniel Kraft, M.D., IntelliMedicine, 2013 Kevin Kruse, Axiom Professional Health Learning, 2006 Ryo Kubota, M.D., Ph.D., Acucela, 2011 Kevin Kucharski, Achillion Pharmaceuticals, Inc., 2015 Jeff Kueffer, INC Research, 2013 Vijai Kumar, M.D., Excel Life Sciences, 2010 Dale Kummerle, Pharm.D., BristolMyers Squibb, 2012 Rebecca Daniels Kush, Ph.D., CDISC, 2008 Boris Kushkuley, Intouch Solutions, 2015 L Lisa La Luna, ePharmaSolutions, 2007 Mark Laabs, Rare Cancer Research Foundation, 2014 Laurent Labrune, Cegedim, 2012 Cynthia LaConte, Dohmen Life Science Services, 2015 Mary Lacquaniti, Healthcare Communication & Marketing Association, 2008 Mark Lacy, Benchmark Research, 2011 Michael Laferrera, Barrier Therapeutics Inc., 2008 Betsy Lahue, Becton, Dickinson and Company, 2012 Sanjit Singh Lamba,MD, Eisai Pharmatechnology, 2012, 2015 Alex Lancksweert, GlaxoSmithKline, 2011 Mark Landy, DDS, MIV Therapeutics Inc., 2008 Jim Langford, DataLabs Inc., 2006 Robert Lanza, M.D., Advanced Cell Technology Inc, 2007 Todd LaRoche, Palio, 2012 Stefan Larsson, The Boston Consulting Group, 2013 Rob Laurens, BBK Worldwide, 2007 Ted Lawrence, Lawrence & Company, 2009 Jessica Lea, Tria Health, 2013 John Lechleiter, Ph.D., Eli Lilly and Company, 2011 Doreen Lechner, Ph.D., Sentrx, a part of Telerx, 2013 Eugene Lee, Communications Media Inc, 2014 Jorge Lee, Questcor Pharmaceuticals, 2013 Philip Lee, PHT, 2011 Michael Lehmann, Patheon, 2013 Chitra Lele, Ph.D., Sciformix, 2014 Michael Leonetti, Boehringer Ingelheim Pharmaceuticals Inc, 2008 Guillaume Leroy, Sanofi Pasteur, 2015 Patricia Leuchten, The Avoca Group, 2011 Ilyssa Levins, Center for Communication Compliance, 2012 Arthur Levinson, Ph.D., Genentech, 2006 Kimberly Levy, MicroMass Communications, 2009 Warren Levy, Ph.D., Unigene Laboratories, 2010 R.J. Lewis, eHealthcare Solutions, 2013 Freda Lewis-Hall, M.D., Pfizer, 2011, 2014, and 2015 Red Jacket Zorba Lieberman, Citeline Inc., 2008 Mary Ann Liebert, Mary Ann Liebert Inc. publishers, 2005 Rob Likoff, Group DCA, 2010 Patrick Lindsay, United BioSource Corp., 2007 Laura Liotta, Sam Brown Inc., 2015 Craig Lipset, Pfizer, 2010 Jeffrey Litwin, M.D., eResearch Technology, 2012 Marlene Llopiz, M.D., Venn Life Sciences, 2010, 2011 Antony Loebel, Sunovion Pharmaceuticals, 2013 Brian Loew, Inspire, 2014 Evan Loh, M.D., Wyeth Research, 2008 Margaret Long, Astellas Pharma US, 2010 Brian Longo, Veeva, 2013 Sandra R. Lottes, PharmD, United BioSource Corporation, 2015 Cheryl Lubbert, Health Perspectives Group, 2015 Mike Luby, TargetRx Inc., 2006 Gregory Lucier, Invitrogen Corp., 2007 Jan Lundberg, M.B., Ph.D., AstraZeneca, 2006 Nancy Lurker, ImpactRx, 2005 Kevin Lustig, Ph.D., Assay Depot, 2012, 2013 Laura Marsh Lynner, Scientific Voice, 2008 Robert Lyons, Ph.D., Nextrials Inc, 2005 M Geoff MacKay, Organogenesis, 2006, 2007 Alan MacKenzie, TAP Pharmaceutical Products, 2005 Kathy Magnuson, Brand Pharm, 2008 Ibrahaim Mahmood, DrugDev, 2014 William Maichle, Kowa Pharmaceuticals America Inc, 2009 Lukas Makris, Ph.D., BioCor, 2005 Tonya Mallory, Health Diagnostic Laboratory, 2014 Sarah Mandracchia, BBK Worldwide, 2015 Melissa Manice, Cohero Health, 2015 Alfred Mann, MannKind, 2010 Abby Mansfield, Topin & Associates, 2012 S. Machelle Manuel, Ph.D., Sankyo Pharma Inc., 2005 John Maraganore, Ph.D., Alnylam Pharmaceuticals, 2009 Dominic Marasco, Innovex Inc., 2009 Michael Marcarelli, Pharm.D., FDA, 2010 Peter Marchesini, inVentiv Health, 2009 Mauricha Marcussen, Agano Solutions/Auditgraph, 2013 Barbara Marino, Ph.D., PHT Corp., 2010 JeanMarie Markham, Clinlogix, 2007 Brian Markison, King Pharmaceuticals, 2006 Michelle Marlborough, Medidata Solutions Worldwide, 2014 Dena Marrinucci, Epic Sciences, 2015 Stacy Mamarkos Martin, Metropolitan Research Associates, 2005 Joseph Martinez, Amylin Pharmaceuticals, 2009, 2012 Mario Martinez II, 360 Vantage, 2012 Bob Mason, Palio, 2008 Guy Mastrion, Palio Communications, 2006 Patrice Matchaba, M.D., Novartis, 2012 Neil Matheson, AXIS Healthcare, 2005 Howard Mayer, M.D., EMD Serono, 2011 Sylvia McBrinn, Vernalis Pharmaceuticals Inc., 2007 Sir Allen McClay, Almac Group, 2011 Tim McCort, inVentiv, GSW, 2013 Philip McCrea, ClearPoint, 2011 Mark McDowell, Wishbone/ITP Inc., 2006 Bill McEllen, Echo Torre Lazur, 2010 PHARMAVOICE 100 CELEBRATION 39 Celebration PHARMAVOICE 100 HONOREES THROUGH THE YEARS Andrea McGonigle, Microsoft, 2013, 2014 Nadine McGowan, The Snow Companies, 2011 Jack McKenzie, Ph.D., Mini Mitter, a Philips Respironics company, 2009 Michael McLaughlin, M.D., Peloton Advantage, 2009 Chuck McLeester, Roska Healthcare Advertising, 2012 Kevin McMurtry, Advanced Health Media, 2005, 2006 Matt McNally, Publicis Health Media, 2014, 2015 Robert McNally, Ph.D., GeoVax, 2010 Bill Meisle, GlaxoSmithKline, 2009 Mary Melia, Shaw & Todd Inc, 2006 Renee Mellas, Wishbone/ITP, 2008 John Mendlein, Ph.D., Atyr Pharma, 2013 Boaz Mendzelevski, M.D., BioClinica, 2014 Mike Menta, Campbell Alliance, an inVentiv Health Company, 2015 James Mercante, TGaS Advisors, 2011 Lars Merk, Johnson & Johnson, 2011 Abbey Meyers, National Organization for Rare Diseases Inc, 2007 Angela Miccoli, Cegedim Dendrite, 2010 Steven Michaelson, Wishbone/ITP Inc., 2006, 2015 Susan Miller Viray, The CementWorks, 2007 Diego Miralles, M.D., Janssen Research & Development, 2012 Jules Mitchel, Ph.D., Target Health Inc., 2014, 2015 DJ Mitsch, Pyramid Resource Group, 2013 Ed Mitzen, Palio Communications, 2005 Elizabeth Moench, MediciGroup Inc., 2005 Ann Mohamadi, PwC, 2013 Paulash Mohsen, Pfizer, 2010 Olivia Montaño-Tritz, SynteractHCR, 2012 Hussain Mooraj, AMR Research, 2009 Michael Morales, Dimensional Healthcare, 2005 Paulo Moreira, EMD Serono, 2015 Ellen Morgan, Synteract, 2009 Joel Morganroth, M.D., eResearch Technology, 2010 Jeff Morhet, InNexus Biotechnology Inc., 2008 Joy Morrell, The Therapeutics Institute, a division of Ventiv Commercial Services, 2005 Rick Morrison, Comprehend Systems, 2012 40 David Mott, MedImmune Inc., 2005, 2008 Wilhelm Muehlhausen, iCON Plc, 2015 Kurt Mueller, Roska Healthcare Advertising, 2011 Keeshia Muhammad, Teva’s Women Health, 2011 Edmundo Muniz, M.D., Ph.D., Certara, 2015 Ciaran Murray, ICON, 2014 Theresa Kane Musser, Rigel Pharmaceuticals Inc., 2005 Kelly Myers, Qforma Inc., 2007 Laurie Myers, Ph.D., Fair Isaac Corp., 2007 Michael Myers, Palio Communications, 2007 N Mario Nacinovich Jr., AXON US, 2005, 2011 Francois Nader, M.D., NPS Pharmaceuticals, 2009 Nader Naeymi-Rad, Campbell Alliance, 2009 Ramin Najafi, Ph.D., NovaBay Pharmaceuticals Inc., 2008 Gail Naughton, Ph.D., Histogen, 2011 Stephen Neale, AbelsonTaylor, 2008 Marcee Nelson, Pink Tank, 2010 Andrew Newbigging, Medidata Solutions Worldwide, 2011 Roger Newton, Ph.D., Esperion Therapeutics, 2006 Graham Nicholls, Almac Clinical Technologies, 2012 Lance Nickens, The Patient Recruitment Agency, 2011 Jan Nielsen, Sonexus Health, 2014 Timothy Noffke, Integrated Project Management Company Inc., 2007 Robert Norris, Complete Healthcare Communications, 2009 John Nosta, NostaLab, 2015 Tina Nova, Ph.D., Genoptix, a Novartis company, 2012 O Michael O’Connell, Ph.D., Insightful Corp., 2005 Lelia O’Connor, Ngal So Authentic Leadership Group, 2008 Francis O’Donnell Jr., M.D., Accentia Biopharmaceuticals, 2007 Michael O’Gorman, Sentrx, a part of Telerx, 2013 Jeanine O’Kane, Biosector 2, inVentiv, 2015 Jim Ogle, INC Research, 2012 Thomas Okarma, Ph.D., M.D., Geron Corp., 2006 Nosa Omoigui, Nervana Inc., 2006 Alan Ong, INC Research, 2015 PHARMAVOICE 100 CELEBRATION Paul Orhii, M.D., Ph.D., Nigerian NAFDAC, 2010 John Orloff, M.D., Baxter BioScience, 2015 David Ormesher, closerlook, 2010, 2011, 2013, and 2014 Red Jacket Susan Orr, O.D., Alcon Inc., 2005 P Nigel Page, i3, 2007 Tim Pantello, PwC, 2015 Darlene Panzitta, DSP Clinical Research, 2012 Michael Parisi, Ogilvy CommonHealth, 2012 Steve Parker Jr., Solos Health LLC, 2007 Julian Parreño, Harte-Hanks, 2008 Cindy Parrott, Community Health Systems, 2012 Vince Parry, Y Brand, 2010 Georgette Pascale, Pascale Communications LLC, 2009 David Passov, ClinStar, 2011 David Pasta, ICON Clinical Research, 2009 Nikin Patel, Molecular Profiles Ltd., 2011 Yvonne Paterson, Ph.D., University of Pennsylvania / Advaxis Inc., 2014 Philip Patrick, PharmaStrat Inc., 2005 Tiffany Patrick, Clinical Practice Insights, 2011 Kristin Patton, HealthEd Group, 2008 Jean Paty, Ph.D., invivodata Inc, 2007 Robert Paull, Lux Capital Management, 2010 Devin Paullin, Physicians Interactive, 2010 Krista Payne, United BioSource Corp., 2014 Stuart Peltz, Ph.D., PTC Therapeutics, 2009, 2015 Edward Penhoet, Ph.D., Alta Partners, 2005 Javier Revuelta Pérez, Ph.D., Pharm.D., INC Research, 2011 Chris Perkin, Algorithme Pharma, 2015 Adelene Perkins, Infinity Pharmaceuticals, 2012 Susan Perlbachs, GSW, 2014 Dan Perlman, RPS, 2013 Jennifer Peters, Greenphire, 2015 Robert Peters, MicroMass Communications, 2012 Kenneth Phelps, Camargo Pharmaceutical Services, 2009 Donald Phillips, Pharm.D., Vox Medica, 2008 Jack Phillips, Roche Diagnostics, 2012 Kristin LaBounty Phillips, The Patient Experience Project, 2015 Marci Piasecki, Torre Lazur McCann, 2007 Richard Piazza, Pharm.D, etrials Worldwide Inc., 2006 Joe Pieroni, Daiichi Sankyo, 2010 Christine Pierre, Rx Trials and Society for Clinical Research Sites, 2009, 2013 Michael Pietrack, TMAC Direct, 2015 Art Pirrone, Modular Thermal Thechnologies, 2013 Robert Piwko, C3i, 2010 Michael Platt, Fission Communications, 2006 Scott Plevy, M.D., Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, 2015 Bill Pollock, Pharmagistics Group, 2008 Stephen Pomeranz, M.D., ProScan Imaging and ProScan Educational Foundation, 2007 Timothy Poole, Pharm.D., Pfizer, 2007 Christine Poon, Johnson & Johnson, 2006 Chris Porter, Clinipace Inc, 2008 Jack Porter, DecisionView Software, 2006 Miranda Pothiawala, Samarind Ltd., 2014 Frank Powers, Dudnyk, 2011 James Powers, HemoShear, 2014 Timothy Pratt, Ph.D., MedNet Solutions, 2005 Sharon Presnell, Organovo, 2013 Robert Previdi, PSKW, 2012, 2013, 2014 Beth Anne Price, The Medical Affairs Company, 2007, 2015 Philip Priest, GlaxoSmithKline, 2011 Josh Prince, The CDM Group, 2012 Barbara Pritchard, The Pritchard Group, 2005 Anna Protopapas, Millennium Pharmaceuticals, 2014 Charlene Prounis, FlashPoint Medica, 2005 Ahnal Purohit, Ph.D., Purohit Navigation, 2009, 2010 James Pusey, M.D., Omnicare Clinical Research, 2010 Andy Pyfer, Fingerpaint, 2015 Q Patricia Quilty, Archives of Internal Medicine and Archives of Dermatology, 2006 R John Racik, Stonefly Communications Group, 2008 George Rafols, PharmaLinkFHI, 2006 Celebration Julia Ralston, MedErgy HealthGroup, 2007 Sumant Ramachandra, M.D., Ph.D., Hospira Inc., 2011 Donna Ramer, StrategCations Inc, 2009 Kim Ramko, Ernst & Young, 2013 Laura Randa, GlaxoSmithKline, 2013 Ken Rapp, Accelrys, 2013 Ramesh Raskar, MIT Media Lab, 2013 Pam Rattananont Ferris, Core Principle Solutions, 2011 Amrit Ray, M.D., Pfizer, 2005 Stephen Raymond, Ph.D., PHT, 2006 Mike Rea, IDEA Pharma, 2011, 2013, 2015 David Rear, R.Ph., Advanced Clinical Concepts, 2013 Robert Rebak, QualityHealth, 2011 Dana Reeve, Christopher Reeve Foundation, 2006 Maureen Regan, Regan Campbell Ward, 2006 Alan Reicheg, Qforma, 2010 Clifford Reid, Ph.D., Complete Genomic, 2010 Elizabeth Reid, Duke Clinical Research Insitute, 2011 Patrick Revelle, MedDRA MSSO, 2008 Ken Ribotsky, Brandkarma, 2014 Katrina Rice, eClinical Solutions, 2011 Linda Richardson, Reliant Pharmaceuticals, 2008 Scott Richardson, Pfizer, 2012 Melinda Richter, Johnson & Johnson, 2015 Elaine Riddell, TNS Healthcare, 2008 Zack Rinat, Model N, 2005 Jamie Ring, Genzyme, 2013 Tobias Ritter, Ph.D., SciFluor Life Sciences, 2012 Alessandro Riva, Novartis AG, 2014 Adrienne Robinson, Merck, 2013 Harriet Robinson, Ph.D., GeoVax, 2011 Jim Robinson, Astellas Pharma US, Inc., 2015 Sheila Rocchio, PHT, 2012 James Rogers, Nextrials Inc., 2007 Mary Rose Rogowski, PulseCX, 2015 Michelle Rohrer, Ph.D., Genentech, 2014 Bruce Rooke, GSW, 2010 Linda Rosenes, Pfizer, 2012 Allen David Roses, M.D., GlaxoSmithKline, 2005 Lorin Roskos, Ph.D., Abgenix, 2005 Julie Ross, Advanced Clinical LLC, 2014 Duane Roth, Connect, 2014 William Roth, Blue Fin Group, 2008 Karen Roy, Phlexglobal, 2014 Maryellen Royle, Tonic Life Communications, 2015 Sydney Rubin, inVentiv Health, 2014 Darielle Ruderman, GlaxoSmithKline, 2011 Robert Ruffolo Jr., Ph.D., Wyeth, 2005 Nancy Ruiz, M.D., Meda Pharmaceuticals, 2014 Vera Rulon, Pfizer, Inc., 2015 Angus Russell, Shire Pharmaceuticals, 2009 Chan Russell, Lincoln Technologies/ Phase Forward, 2007 Richard Russell, Sunovion Pharmaceuticals, 2013 Mike Rutstein, DraftFCB NY, 2008, 2012 John Ryals, Ph.D., Metabolon Inc, 2005 Una Ryan, Ph.D., Diagnostics for All, 2010 S Ryan Saadi, M.D., Johnson & Johnson, 2011, 2015 Helen Sabzevari, Ph.D., EMD Serono, 2013 Dinah Sah, M.D., Voyager Therapeutics, 2014 M. Scott Salka, Ambit Biosciences, 2006 Dr. Niranjan Y. Sardesai, Inovio Pharmaceuticals, 2015 Brent Saunders, Schering-Plough Corp., 2009 George Savage, M.D., Proteus Digital Health, 2014 James Sawyer, MBChB, Prism Ideas, 2011 Adriann Sax, King Pharmaceuticals Inc., 2008 George Scangos, Ph.D., Exelixis Inc., 2006 Don Schenker, Synergistix, 2008, 2009, 2011 Barry Schmader, Dudnyk, 2009 Dan Schneider, Consultant, 2009 Laurent Schockmel, DVM, Cegedim Dendrite, 2009 Anne Faulkner Schoemaker, Neuronyx Inc., 2007 James Schoeneck, BrainCells Inc., 2008 Peter Scholes, Ph.D., Quotient Bioresearch, 2010 Chris Schroeder, The HealthCentral Network, 2008, 2009 Lawrence H. Schwartz, M.D., Memorial Sloan-Kettering Cancer Center, 2005 Fatima Scipione, Millennium Pharmaceuticals, 2013 Kevin Scott, Johnson & Johnson, 2010 Dr. Theodore Search, Skipta, 2015 Alex Sefanov, Perficient Inc., 2014 Leerom Segal, Klick Health, 2012, 2013, 2014, and 2015 Red Jacket David Segarnick, MedEvoke, 2013 Ed Seguine, Clinical Ink, 2012 Karen Seibert, Ph.D., Pfizer Global Research and Development, 2008 Stephen F. Sener, M.D., American Cancer Society, 2005 Emma Sergeant, Fast4wD Ogilvy, 2009 Susan Seroskie, Advanced Clinical LLC, 2014 Satwik Seshasai, NextDocs, 2013 Rachel Sexton, VPR Patient Outreach Program, 2014 Lecia Shaffer, Nextrials Inc., 2009 Sandeep Shah, Skyscape Inc., 2008 Kabir Shahani, Appature, 2012 Kevin Sharer, Amgen, 2006 Christi Shaw, Novartis AG, 2015 Duncan Shaw, MediciGlobal, 2011 Paul Shawah, Veeva, 2012 Lauren Shawver, Ph.D., Cleave Biosciences, 2012 Lori Shields, Medidata Solutions Worldwide, 2009 Kirk Shepard, Baxter Healthcare, 2015 Todd Sherer, Ph.D., The Michael J. Fox Foundation for Parkinson’s Research, 2012 Leo Sheridan, Advanced Clinical, 2015 Tarek Sherif, Medidata Solutions Worldwide, 2007 Adam Sherlock, CSC, 2012 Nicolette Sherman, Sanofi, 2014 Blake Shewey, Snow Companies, 2015 Joe Shields, Pfizer, 2010 Mollie Shields-Uehling, SAFEBioPharma Association, 2008 Martin Shkreli, Retrophin, 2013 Kuslima Shogen, Alfacell, 2005 Ken Shore, Blue Chip Patient Recruitment, 2014 Charlotte Sibley, Shire Pharmaceuticals, 2006 Jay Philip Siegel, M.D., Janssen Research & Development, 2012 Peter Siegel, The Hal Lewis Group, 2007 Michael Simone, The Snow Companies, 2011 Graham Simpson, GlaxoSmithKline, 2013 Raman Singh, Mundipharma, 2014 Marc Sirockman, Artcraft Health, 2013, 2015 Albert Siu, PAREXEL, 2015 Dan Skovronsky, M.D., Ph.D., Avid Radiopharmaceuticals, 2007 Todd Skrinar, EY, 2014 Tim Slevin, Veeva Systems, 2015 Nancy Smerkanich, Octagon Research Solutions Inc., 2005 Andy Smith, Palio, 2009 Christine Smith, Pfizer Global Research and Development, 2007 Dorothy Smith, Pharm.D., Consumer Health Information Corp., 2008 Peter Smith, Ph.D, Millennium: The Takeda Oncology Co., 2009 Stephen Smith, Medidata Solutions, 2015 Brenda Snow, The Snow Companies, 2007, 2010 Mike Soenen, ClearTrial, 2010 Martin Soeters, Novo Nordisk, 2005, 2007 Jean-Pierre Sommadossi, Ph.D., Pharm.D., Idenix Pharmaceuticals, 2005 Donald Soong, Cegedim Relationship Management, 2014 Craig Sorensen, Ph.D., Vertex Pharmaceuticals, 2010 Rodney Spady, Novartis Consumer Health Inc., 2008 Jeff Spanbauer, Healthcare Regional Marketing, 2012 Ira Spector, Wyeth Pharmaceuticals, 2007 Shelley Spencer, Total Learning Concepts and Arista Marketing, 2007 John Spitznagel, Oceana Therapeutics, 2006, 2010 Badhri Srinivasan, Quintiles, 2014 Nagarajan Srivatsan, Cognizant, 2010 Andrew Stanger, GenR Media, 2012 Larry Star, Harrison & Star, 2005, 2010 Joseph Stauffer, D.O, Alpharma, 2007 Abbe Steel, United BioSource Corp., 2013 Jeffrey Stein, Ph.D., Trius Therapeutics, 2009 Susan Stein, Connexion Healthcare, 2005 Howard Steinberg, dLife – For Your Diabetes Life!, 2008 Annette Stemhagen, Dr.PH., United BioSource Corp., 2011 Keith Stenlund, AbelsonTaylor, 2015 Hugo Stephenson, M.D., iGuard.org, a Quintiles Co., 2010 David Stern, Serono, 2005 Robert Stern, Projects In Knowledge, 2009 Dr. Leo H. Sternbach, Roche, 2005 Betsy Brown Stewart, Trio Clinical Research, 2007, 2012 Mark Stinson, Stinson Brand Innovation Inc., 2009 Robert Stirling, McNeil Consumer Healthcare, 2007 Kim Stratton, Novartis AG, 2011 PHARMAVOICE 100 CELEBRATION 41 Celebration PHARMAVOICE 100 HONOREES THROUGH THE YEARS Pam Strobel, inVentiv Health Clinical, 2013 William (Bill) R. Strohl, Ph.D., Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, 2015 Peter Strumph, Nile Therapeutics Inc., 2008 Matthew Stumm, BBK Worldwide, 2013 Anish Suri, Ph.D., Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, 2015 Danita Sutton, Ph.D., MedErgy HealthGroup, 2008 Robert Swanson, Genentech, 2005 Steve Swanson, Imperial, 2013 Jeff Sweeney, Regan Campbell Ward Group, 2011 Rita Sweeney, Dorland Global Corp, 2006 Judy Swilley, Ph.D., INC Research, 2014 Zikria Syed, NextDocs Corp., 2007 Maryann Szabo, Roche, 2010 Ana Szarfman, M.D., Ph.D., U.S. Food and Drug Administration, 2007 Kenneth Tomaszewski, Ph.D., KJT Group, 2012 Joseph Tonning, M.D., M.P.H., R.Ph., Food and Drug Administration, 2008 Alan Topin, Topin & Associates, 2009 Terrence Tormey, BrandParents, 2005 Susan Torroella, Columbia MedCom Group, 2005 Donato Tramuto, Physicians Interactive, 2005, 2009, 2012, and 2014 Red Jacket Lois Trench-Hines, Meniscus Ltd, 2005 Chris Trizna, CSSi, 2014 Jeff Trotter, PharmaNet, 2010 Nancy Mensch Turett, Edelman, 2007 T V Bill Taaffe, ICON, 2011 Leonard Tacconi, Discovery Health, 2007 John Talanca Jr., Novartis, 2006 Francis Tally, M.D., Cubist Pharmaceuticals Inc., 2006 Nobuhiko Tamura, Sunovion, 2011 Jeff Tangney, Epocrates, 2007 Alison Taunton-Rigby, Ph.D., O.B.E., RiboNovix Inc., 2006 Dale Taylor, AbelsonTaylor, 2005 Jeff Taylor, Columbia MedCom Group, 2007 David Templeton, Enzon Pharmaceuticals, 2007 Angela Tenuta, Intouch Solutions, 2014 Robert Teoh, M.D., i3 Research, 2008 Joe Tetzlaff, i3, 2009 Kent Thoelke, PRA, 2013 Brad Thompson, Ph.D., Oncolytics Biotech Inc, 2005, 2006 David S. Tierney, M.D., Oceana Therapeutics., 2005, 2006, 2011 Victoria Tifft, CRM and M3 Clinical Research, 2007 Uwe Tigör, M.D., Palio, 2011 Mark Timney, Purdue Pharma, 2015 Sreedhar Tirunagari, M.D., MakroCare Clinical Research, 2012 Christopher Tobias, Ph.D., Dudnyk, 2012 42 U Jay Udani, M.D., Medicus Research/ SysteMedicus, 2013 Henrietta Ukwu, M.D., PPD, 2011 Pablo Umaña, Ph.D., Roche GlycArt, 2014 Shaun Urban, Solara and Valos, part of CommonHealth, 2009 Dennis Urbaniak, Sanofi, 2011 Kathy Jo Usher, Bayer Healthcare Dermatology, 2013 Marco van Doeveren, Medidata Solutions Worldwide, 2012 Fredrick Van Goor, Ph.D., Vertex Pharmaceuticals, 2011 Richard Vanderveer, Ph.D., GfK, 2005 Ken VanLuvanee, Virtual Regulatory Solutions, 2014 Martin VanTrieste, R.Ph., Amgen, 2012 Daniel Vasella, M.D., Novartis, 2005, 2006, 2009 Vikas Vats, marketRx, 2007 Tristan Vaughan, Ph.D., MedImmune, 2011 Leonard J. Vicciardo, inVentiv Pharma Analytics, 2006 Chris Viehbacher, Sanofi-Aventis, 2010, 2011 Dr. Brad Vince, Vince and Associates Clinical Research, 2015 L. Stephan Vincze, TAP Pharmaceutical Products Inc, 2007 Dr. Giulio Vita, Bristol-Myers Squibb, 2005 Steve Viviano, ICC Lowe, 2012 Polina Voloshko, M.D., Gentiae, 2006 Darik Volpa, Understand.com, 2013 Alexandra von Plato, Publicis Healthcare Communications, 2013 Josef von Rickenbach, Parexel International Corp., 2007 PHARMAVOICE 100 CELEBRATION Lynn O’Connor Vos, Grey Healthcare Group, 2005 Ruth Vukelich, PLEXUS Learning Designs Inc., 2005 Saru Wade, Vertex Pharmaceuticals, 2012 W Ronald Waife, Waife & Associates Inc., 2008 Tim Walbert, Horizon Pharma, 2010, 2015 James Walker, Octagon Research Solutions, 2010 Steven Walker, MedImmune, 2012 Jon Wallace, CV Therapeutics, 2005 Matt Wallach, Verticals onDemand Inc., 2007 Neill “Gobie” Walsdorf, Jr., Mission Pharmacal Company, 2015 Meg Walsh, CommonHealth, 2008 Blane Walter, inChord Communications, 2005 Anna Walz, Medisys Health Communications, 2012 Brendan Ward, Regan Campbell Ward, 2009 Gail Wasserman, Ph.D., MedImmune, 2011 Scott Watson, Ogilvy CommonHealth, 2010 Bob Weiler, Phase Forward, 2006 Marc Weiner, Ogilvy CommonHealth Worldwide, 2013 Michael Weintraub, Humedica, 2010 Scott Weintraub, Healthcare Regional Marketing, 2011 Howard Weisman, EKR Therapeutics Inc., 2008 Neil Weisman, Blue Chip Healthcare Marketing, 2011 Carol Wells, Genentech, 2010 Jean-Pierre Wery, Ph.D., Crown Bioscience Inc., 2014, 2015 Matthew West, Regan Campbell Ward, 2013 Christoph Westphal, M.D., Ph.D., Sirtris Pharmaceuticals Inc., 2008 Sarah Wharmby, Bristol-Myers Squibb, 2011 Carl Whatley, ProEthic Pharmaceuticals Inc., 2008 Mark Wheeldon, Formedix, 2014 Samuel Whitaker, Greenphire, 2013 John White, R.Ph., The Medical Affairs Company, 2014 Ted White, Novartis, 2010 Wendy White, Dohmen Lfie Science Services, 2012, 2015 Thomas Wicks, TrialScope, 2015 Sarah Wilcox, Draft Health Inc., 2006 Nila Williams, Clinsys Clinical Research Inc., 2008 Jeffrey Williams, Clinipace, 2007 Leslie Williams, Ventaira Pharmaceuticals, 2006 Engelbert Tjeenk Willink, M.D., Boehringer Ingelheim Pharmaceuticals Inc, 2009 Mark Willmann, Torre Lazur McCann, 2011 Renee Wills, ICC Lowe Trio, 2013 Glynn WIlson, TapImmune, 2015 Zane Wilson, The South African Depression and Anxiety Group, 2007 Jeff Wiltrout, Ph.D., GlaxoSmithKline, 2006 Robin L. Winter-Sperry, M.D., Scientific Advantage LLC, 2005, 2013 Andrew Witty, GlaxoSmithKline, 2009 Janet Wolfe, Ph.D., Wolfe Laboratories, 2010 Corbin Wood, Snow Companies, 2014 David Wood, Interbrand Wood Healthcare, 2005 Deborah Wood, DWA Healthcare Communications Group, 2010, 2015 Nicole Woodland, compas, inc., 2015 Stan Woodland, CMI and Compas Inc., 2008 Stephen Wray, Cadient Group, 2012 Larry Wright, Ph.D., MedErgy HealthGroup, 2009 Timothy Wright, M.D., Novartis, 2012 Sandra Wrobel, Applied Strategies Consulting Inc., 2007 Stanley Wulf, M.D., InfoMedics, 2009 Graham Wylie, MBBS, The Medical Research Network, 2014 Rachael Wyllie, CRF Health, 2015 Nancy Wysenski, EMD Pharmaceuticals, 2006 André Wyss, Novartis, 2013 Y Rosemarie Yancosek, ScheringPlough Corp., 2007 Natalie Yeadon, Genentech, 2007 Lihua Yu, H3Biomedicine, 2015 Z Christine Zak, DAS-Omnicom, 2006, 2015 David Zaritsky, Roska Healthcare, 2006, 2013 Meryl Zausner, Novartis, 2014 Silvia Zieher, M.D., INC Research, 2010 Howard Ziment, Ziment Group, 2006 Jeanne Zucker, InfoMedics Inc, 2008 Andrew Zupnick, Novella Clinical, 2015 ALEXANDRIA CENTER® FOR LIFE SCIENCE – NEW YORK CITY New York City’s first and only urban science and technology campus, providing a dynamic, creative, and collaborative office/laboratory environment for leading science and technology companies at the forefront of innovation. Alexandria Real Estate Equities, Inc. | www.are.com WE MAKE LIFE CHANGING PLACEMENTS SO OUR CLIENTS CAN CHANGE LIVES!® benchinternational.com